<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Hypotheses about sub-optimal hydration in the weeks before coronavirus disease (COVID-19) as a risk factor for dying from COVID-19</title>
			</titleStmt>
			<publicationStmt>
				<publisher>Elsevier BV</publisher>
				<availability  status="unknown">
					<licence/>
				</availability>
				<date type="published" when="2020-11">02 September 2020 0306</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><forename type="first">Jodi</forename><forename type="middle">D</forename><surname>Stookey</surname></persName>
							<email>jodi.stookey@asu.edu</email>
							<affiliation key="aff0">
								<orgName type="department">College of Health Solutions</orgName>
								<orgName type="laboratory">Hydration Science Lab</orgName>
								<orgName type="institution">Arizona State University</orgName>
								<address>
									<settlement>Phoenix</settlement>
									<region>AZ</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Prasanna</forename><forename type="middle">K R</forename><surname>Allu</surname></persName>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Section on Integrative Physiology and Metabolism</orgName>
								<orgName type="department" key="dep2">Joslin Diabetes Center</orgName>
								<orgName type="institution">Harvard Medical School</orgName>
								<address>
									<settlement>Boston</settlement>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Dorothee</forename><surname>Chabas</surname></persName>
							<affiliation key="aff2">
								<orgName type="institution">Neuroesthetics</orgName>
								<address>
									<settlement>San Francisco</settlement>
									<region>CA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">David</forename><surname>Pearce</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Department of Medicine</orgName>
								<orgName type="institution">University of California</orgName>
								<address>
									<settlement>San Francisco</settlement>
									<region>CA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Florian</forename><surname>Lang</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Department of Physiology</orgName>
								<orgName type="institution">Eberhard Karls University</orgName>
								<address>
									<addrLine>631 Lyon St</addrLine>
									<postCode>72074 94117</postCode>
									<settlement>Tubingen San Francisco</settlement>
									<region>CA</region>
									<country>Germany United States</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Hypotheses about sub-optimal hydration in the weeks before coronavirus disease (COVID-19) as a risk factor for dying from COVID-19</title>
					</analytic>
					<monogr>
						<title level="j" type="main">Medical Hypotheses</title>
						<title level="j" type="abbrev">Medical Hypotheses</title>
						<idno type="ISSN">0306-9877</idno>
						<imprint>
							<publisher>Elsevier BV</publisher>
							<biblScope unit="volume">144</biblScope>
							<biblScope unit="page">110237</biblScope>
							<date type="published" when="2020-11">02 September 2020 0306</date>
						</imprint>
					</monogr>
					<idno type="MD5">1296568DE9DAAAF0F201BCEB510DEB5E</idno>
					<idno type="DOI">10.1016/j.mehy.2020.110237</idno>
					<note type="submission">Received 24 June 2020; Received in revised form 20 August 2020; Accepted 30 August 2020</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-10-04T11:29+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=0, consolidateHeader=1, consolidateFunders=0, includeRawAffiliations=false, includeRawCitations=false, includeRawCopyrights=false, generateTeiIds=false, generateTeiCoordinates=[], sentenceSegmentation=false, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>Chronic hydration Hypertonicity COVID-19 Mortality ACE2 receptors</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>To address urgent need for strategies to limit mortality from coronavirus disease 2019 , this review describes experimental, clinical and epidemiological evidence that suggests that chronic sub-optimal hydration in the weeks before infection might increase risk of COVID-19 mortality in multiple ways. Sub-optimal hydration is associated with key risk factors for COVID-19 mortality, including older age, male sex, race-ethnicity and chronic disease. Chronic hypertonicity, total body water deficit and/or hypovolemia cause multiple intracellular and/or physiologic adaptations that preferentially retain body water and favor positive total body water balance when challenged by infection. Via effects on serum/glucocorticoid-regulated kinase 1 (SGK1) signaling, aldosterone, tumor necrosis factor-alpha (TNF-alpha), vascular endothelial growth factor (VEGF), aquaporin 5 (AQP5) and/or Na + /K + -ATPase, chronic sub-optimal hydration in the weeks before exposure to COVID-19 may conceivably result in: greater abundance of angiotensin converting enzyme 2 (ACE2) receptors in the lung, which increases likelihood of COVID-19 infection, lung epithelial cells which are pre-set for exaggerated immune response, increased capacity for capillary leakage of fluid into the airway space, and/or reduced capacity for both passive and active transport of fluid out of the airways. The hypothesized hydration effects suggest hypotheses regarding strategies for COVID-19 risk reduction, such as public health recommendations to increase intake of drinking water, hydration screening alongside COVID-19 testing, and treatment tailored to the pre-infection hydration condition. Hydration may link risk factors and pathways in a unified mechanism for COVID-19 mortality. Attention to hydration holds potential to reduce COVID-19 mortality and disparities via at least 5 pathways simultaneously.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Why do people die from COVID-19?</head><p>COVID-19 triggers an immune response in the lungs that is described as a "cytokine storm" in the lay press and acute respiratory distress syndrome (ARDS) in the scientific literature <ref type="bibr" target="#b4">[5]</ref>. "Inflammation spikes, and fluid and dying cells fill the lung sacs, essentially drowning the patient <ref type="bibr" target="#b5">[6]</ref>." The inflammation "makes the membranes between the air sacs and blood vessels more permeable, which can fill the lungs with fluidâ€¦In severe cases, you basically flood your lungs and you can't</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Background</head><p>There is an urgent need for strategies to limit mortality from coronavirus disease 2019 (COVID- <ref type="bibr" target="#b18">19)</ref>. Coronavirus is expected to infect up to 70% of the world's population and kill millions of people <ref type="bibr" target="#b0">[1]</ref>. To date, the main public health strategy for limiting mortality, to reduce exposure to the virus via physical distancing, carries tremendous economic costs <ref type="bibr" target="#b1">[2]</ref> and may create COVID-19 disparities, as not everyone can telecommute for work or afford to shelter in place <ref type="bibr" target="#b2">[3]</ref>. The main treatment strategy for limiting mortality involves ventilators, which may not be available and accessible in adequate quantities <ref type="bibr" target="#b3">[4]</ref>. To address need for strategies that are less costly, more equitable, and more accessible, this paper describes potential causal paths from suboptimal hydration before COVID-19 infection to increased morbidity and mortality. The hypothesized mechanisms suggest potential for free or low-cost, globally applicable drinking water interventions and hydration-informed treatment (e.g. hypertonic resuscitation) to limit COVID-19 mortality. breathe <ref type="bibr" target="#b5">[6]</ref>." Death from ARDS is strongly associated with positive total body water (TBW) balance, i.e. body water retention <ref type="bibr" target="#b6">[7]</ref> (see Fig. <ref type="figure">1</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Risk factors for COVID-19 death</head><p>Death from COVID-19 is strongly associated with older age, male sex, and age-related chronic health conditions <ref type="bibr" target="#b7">[8]</ref><ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref>. The United States (US) Centers for Disease Control (CDC) highlights the following risk factors: residence in a nursing home or long-term care facility, chronic lung disease or moderate to severe asthma, serious heart conditions, severe obesity (body mass index &gt; 40), diabetes, renal failure, liver disease, and/or weakened immune system due to cancer treatment, smoking, bone marrow or organ transplantation, immune deficiencies, poorly controlled HIV or AIDS, and prolonged use of corticosteroids and other immune weakening medications <ref type="bibr" target="#b9">[10]</ref>. In the US and United Kingdom (UK), consistent with obesity, diabetes, cardiovascular and chronic kidney disease disparities, ethnic minorities are at increased risk of dying from COVID-19 <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b11">12]</ref>.</p><p>Although not specified on the CDC's list of risk factors <ref type="bibr" target="#b9">[10]</ref>, given the ARDS literature (e.g. Rahmel et al. <ref type="bibr" target="#b6">[7]</ref>), a propensity to retain body water when stressed or challenged is partially recognized as a risk factor for COVID-19 ARDS death. Recommendations for COVID-19 ARDS treatment explicitly aim to achieve a negative fluid balance of 0.5-1.0 L/d <ref type="bibr" target="#b12">[13]</ref>. This paper posits that attention to hydration may not only increase the success of treatment for ARDS but may also prevent the development of ARDS and positive fluid balance during COVID-19 infection, in the first place.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Hypotheses</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Hypothesized mechanism</head><p>This paper hypothesizes that, compared to people who survive COVID-19, people who die from COVID-19 have too much fluid accumulating in their lungs, in part because of chronic suboptimal hydration before infection with COVID-19. Chronic hypertonic stress causes a wide variety of metabolic and physiologic adaptations throughout the body <ref type="bibr" target="#b13">[14]</ref>, which alter intracellular composition and response to subsequent hypo-osmotic challenge. Infection triggers an inflammatory response which signals body water retention and vessel dilation, creating relatively hypotonic conditions. Chronic hypertonicity, TBW deficit and/or hypovolemia in the weeks before COVID-19 infection are hypothesized to result in one or more adaptations, including:</p><p>â€¢ Greater abundance of angiotensin converting enzyme 2 (ACE2) re- ceptors in the lung, which increases likelihood of COVID-19 infection.</p><p>â€¢ Lung epithelial cells which are pre-set for exaggerated immune re- sponse.</p><p>â€¢ Increased capacity for capillary leakage of fluid into the airway space.</p><p>â€¢ Reduced capacity for active transport of fluid out of the airways.</p><p>â€¢ Reduced capacity for passive transport of fluid out of the airways.</p><p>Fluid accumulating in the lungs results from an imbalance between passive and active forces driving fluid into the airspaces and mechanisms removing fluid from the airspace <ref type="bibr" target="#b14">[15,</ref><ref type="bibr" target="#b15">16]</ref>. The multiplicity of factors influencing the balance of forces suggests need for intervention strategies that attend to multiple factors, simultaneously.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Evidence motivating the hypotheses</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Overview</head><p>The rationale begins by linking the CDC's list of risk factors for COVID-19 death with increased likelihood of suboptimal hydration, expressed in terms of hypertonicity, TBW deficit and/or hypovolemia. Suboptimal hydration is, next, linked with each of the adaptations, listed above, by experimental, clinical, and epidemiological evidence. Metabolic intermediates or pathways that mediate effects of suboptimal hydration are identified. Experiments and clinical trials that intervene against these mechanisms and increase survival from ARDS are described.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Risk factors for COVID-19 death are associated with indices of suboptimal hydration</head><p>Hypertonicity, TBW deficit and/or hypovolemia are prevalent among people who are at increased risk for COVID-19 death. In population-representative datasets, a majority of older adults have plasma hypertonicity <ref type="bibr" target="#b16">[17,</ref><ref type="bibr" target="#b17">18]</ref>. In the US, hypertonicity is significantly more frequent among males than females <ref type="bibr" target="#b16">[17]</ref> and among Black or African Americans and Hispanics compared to Asians (78-79% vs 55%) <ref type="bibr" target="#b17">[18]</ref>. Hypovolemia is common among residents of nursing home or long-term care facilities <ref type="bibr" target="#b18">[19,</ref><ref type="bibr" target="#b19">20]</ref>.</p><p>Hypertonicity is associated with chronic disease risk factors for COVID-19 death. The prevalence of hypertonicity in non-acutely ill US adults ages 51-70 years who have obesity, high waist circumference, insulin resistance, diabetes, hyperglycemia, glycosylated hemoglobin, dyslipidemia, hypertension and/or metabolic syndrome is 73%, compared to 56% among individuals without any of the listed conditions, in the same age group <ref type="bibr" target="#b17">[18]</ref>. Systematic review of observational studies suggests that hypernatremia is consistently associated with metabolic syndrome <ref type="bibr" target="#b20">[21]</ref>. Animal models and observational studies implicate hypertonicity and the vasopressin-hydration system in the etiology of Fig. <ref type="figure">1</ref>. Reproduced with permission from Rahmel et al <ref type="bibr" target="#b6">[7]</ref>. Mean cumulative fluid balance with 95% CI for survivors and non-survivors of ARDS until ICU day 30. chronic kidney disease <ref type="bibr" target="#b21">[22]</ref>. Hypovolemia is an established risk factor for renal failure in the ICU <ref type="bibr" target="#b22">[23]</ref>.</p><p>Beyond older age, male sex, race-ethnicity and metabolic syndrome, hypertonicity and/or hypovolemia are also associated with asthma, liver disease, and impaired immune function, other risk factors for COVID-19 death highlighted by the CDC <ref type="bibr" target="#b9">[10]</ref>. Bronchial hyperresponsiveness in asthma is associated with hypertonicity <ref type="bibr" target="#b23">[24]</ref>. The pathogenesis of cirrhosis involves vasopressin/antidiuretic hormone, low effective circulatory volume and retention of sodium and water <ref type="bibr" target="#b24">[25]</ref>. Hypertonicity suppresses innate and adaptive immune responses <ref type="bibr" target="#b25">[26]</ref>. For US adults ages 50-70 years, hypertonicity doubles the risk of allcause mortality within 3 to 6 years <ref type="bibr" target="#b17">[18]</ref> and has been proposed as a biomarker of general frailty <ref type="bibr" target="#b26">[27]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Suboptimal hydration causes body water retention</head><p>Hypertonicity, TBW deficit, and hypovolemia trigger changes in metabolism and physiology that favor cell water retention <ref type="bibr" target="#b27">[28]</ref> and TBW retention <ref type="bibr" target="#b28">[29]</ref>. Responses to acute and chronic hypertonicity are distinct <ref type="bibr" target="#b29">[30]</ref>. Multiple metabolic and physiologic responses co-occur impacting multiple pathways and organ systems simultaneously <ref type="bibr" target="#b13">[14,</ref><ref type="bibr" target="#b29">30]</ref>. In free-living individuals, under conditions of daily life, adaptation to chronic hypertonicity may take weeks <ref type="bibr" target="#b30">[31,</ref><ref type="bibr" target="#b31">32]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acute suboptimal hydration</head><p>Acute extracellular hypertonicity causes water to shift out of cells following the osmotic gradient via aquaporin channels. The cell shrinkage increases intracellular solute concentrations, which activate the Na + ,K + -ATPase, Na + ,K + ,2Cl -co-transporter and the Na + / H + exchanger, which couple to Cl -/H2CO3, to enhance cellular osmolarity and restore cell volume <ref type="bibr" target="#b32">[33]</ref>.</p><p>At the whole-person level, acute hypertonic shrinkage of osmoreceptor cells and/or hypovolemia activate the hypothalamic-pituitaryadrenal (HPA) axis and renin-angiotensin-aldosterone system (RAAS). Acute hypertonicity triggers release of arginine vasopressin, also known as antidiuretic hormone, which stimulates thirst and signals the kidney to concentrate urine and reduce urine volume. Acute hypovolemia triggers the kidney to produce renin, which stimulates the conversion of angiotensinogen to angiotensin 1 (Ang I) in the liver and the conversion of Ang I to angiotensin II (Ang II) by the angiotension-converting enzyme (ACE) in multiple organs, including the lung <ref type="bibr" target="#b33">[34]</ref>. Ang II causes vasoconstriction and secretion of antidiuretic hormone and aldosterone <ref type="bibr" target="#b33">[34]</ref>. Aldosterone binds to mineralocorticoid receptors and stimulates renal and intestinal sodium reabsorption by upregulating ENaC and Na + , K + -ATPase.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Chronic suboptimal hydration</head><p>At the cell level, chronic hypertonicity shifts metabolism to favor pathways that accumulate metabolic end-products (osmolytes) of low molecular weight inside the cell. The increased osmolyte concentrations create an osmotic gradient that drives water into the cell. Hypertonic conditions alter the expression of multiple genes. Hypertonicity activates tonicity-responsive enhancer binding protein (TonEBP), also known as nuclear factor of activated T cells (NFAT5), which coordinates increases in the expression of organic osmolyte transporters and enzymes such as aldose reductase (AR), betaine/GABA transporter (BGT1), sodium myoinositol transporter (SMIT) and taurine transporter (TauT) <ref type="bibr" target="#b32">[33]</ref>. Hypertonic conditions induced by high-salt diet decrease expression of renal renin and angiotensinogen-mRNAs compared to normal-and low-salt diets <ref type="bibr" target="#b34">[35]</ref>. Hypertonic conditions reduce expression of the mineralocorticoid receptor that mediates aldosterone effects <ref type="bibr" target="#b35">[36]</ref>. Chronic hypertonicity and hypovolemia increase expression of vascular endothelial growth factor (VEGF) <ref type="bibr" target="#b36">[37,</ref><ref type="bibr" target="#b37">38]</ref>.</p><p>At the physiological level, hypertonicity alters the levels and/or activity of hormones that depend on cell volume, such as insulin <ref type="bibr" target="#b38">[39,</ref><ref type="bibr" target="#b13">14]</ref>, and/or that regulate TBW balance, such as aldosterone.</p><p>Experiments in animals and healthy humans show that hypertonicity induced by high salt diet or hypertonic infusion reduces plasma aldosterone <ref type="bibr" target="#b34">[35,</ref><ref type="bibr" target="#b39">[40]</ref><ref type="bibr" target="#b40">[41]</ref><ref type="bibr" target="#b41">[42]</ref><ref type="bibr" target="#b42">[43]</ref>. Crossover experiments in healthy volunteers report that infusion of 25 ml/kg of a relatively hypertonic solution (osmolarity 614 mOsm/l; tonicity 373 mOsm/l) significantly decreases plasma aldosterone relative to the same volume of a hypotonic solution (osmolarity 447 mOsm/l; tonicity 169 mOsm/l) <ref type="bibr" target="#b42">[43]</ref>. In controlled experiments in healthy humans, hypertonic saline infusion decreases plasma aldosterone and free water clearance <ref type="bibr" target="#b41">[42,</ref><ref type="bibr" target="#b43">44]</ref>.</p><p>In healthy young men with urine osmolality over 800 mmol/kg under conditions of daily life, chronic hypertonicity and mild (&lt; 2%) TBW deficit appear associated with metabolic and physiologic adaptations that result in water retention in response to hypotonic challenge <ref type="bibr" target="#b30">[31]</ref>. Four weeks of sustained higher intake of drinking water (&gt; +1L/ d) is associated with a mean (SE) decrease in HOMA-IR of 2.2 (0.2) to 1.7 (0.1), a mean (SE) increase in plasma aldosterone from 111 <ref type="bibr" target="#b16">(17)</ref> pg/ ml to 143 <ref type="bibr" target="#b18">(19)</ref> pg/ml and an average (SE) increase in body weight of +1.8 (0.5) percent <ref type="bibr" target="#b31">[32,</ref><ref type="bibr" target="#b30">31]</ref>. While significant change in body weight is not detected from one week to the next, the cumulative change over 4 weeks is statistically significant and correlated with increases in serum sodium and a muted change in water turnover <ref type="bibr" target="#b30">[31]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Adaptation to chronic hypertonicity presets for overreaction to hypotonic challenge</head><p>Cells that have adapted to hypertonic conditions are vulnerable to over-swell or lyse if exposed to hypotonic conditions. The higher intracellular osmolyte concentrations draw water in by osmosis. The phenomenon is well-established as a complication of hyperglycemic hypertonic dehydration in diabetic patients <ref type="bibr" target="#b44">[45]</ref>, source of systematic error in the hematology literature <ref type="bibr" target="#b44">[45]</ref>, cause of neuronal excitability <ref type="bibr" target="#b45">[46]</ref>, and hyponatremia associated brain damage <ref type="bibr" target="#b46">[47]</ref>. To protect against lysis, cells adapted to hypertonic conditions release more osmolytes given acute hypotonic challenge, compared to cells maintained in isotonic conditions or cells exposed to repeated hypotonic challenge <ref type="bibr" target="#b47">[48]</ref>.</p><p>In healthy young men with usual total water intake below 2L/d and urine osmolality above 800 mmol/kg, an acute bolus of 750 ml drinking water reduces urine osmolality by over 700 mmol/kg within 60 min. After 4 weeks of total water intake above 3L/d, the corresponding decrease in urine osmolality induced by an acute 750 ml bolus is approximately halved <ref type="bibr" target="#b31">[32,</ref><ref type="bibr" target="#b30">31]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Chronic suboptimal hydration may increase risk of COVID-19 infection</head><p>Hypertonicity may increase risk of COVID-19 infection by reducing aldosterone <ref type="bibr" target="#b34">[35,</ref><ref type="bibr" target="#b39">[40]</ref><ref type="bibr" target="#b40">[41]</ref><ref type="bibr" target="#b41">[42]</ref><ref type="bibr" target="#b42">[43]</ref>, and/or increasing insulin resistance <ref type="bibr" target="#b13">[14,</ref><ref type="bibr" target="#b43">44,</ref><ref type="bibr" target="#b48">49]</ref>, which increase ACE2 receptors. The balance of ACE and ACE2 receptors regulates the RAAS. While ACE converts Ang I to Ang II, which has vasoconstricting effects, ACE2 converts Ang II to Ang-1-9 and Ang-1-7, which have opposite, vasodilating and anti-inflammatory, effects. ACE2 abundance is inversely related with aldosterone <ref type="bibr" target="#b49">[50]</ref>. Hypoaldosteronism is known to interrelate with diabetes and renal insufficiency for persons ages 50-70 years <ref type="bibr" target="#b50">[51]</ref>. In rodent models ACE2 expression is increased by diabetes and decreased by insulin administration <ref type="bibr" target="#b51">[52,</ref><ref type="bibr" target="#b52">53]</ref>. Diabetes is hypothesized to increase risk of COVID-19 infection by increasing ACE2 receptors <ref type="bibr" target="#b53">[54]</ref>.</p><p>Chiusano et al. <ref type="bibr" target="#b54">[55]</ref> propose a model for describing mechanisms involved in COVID-19 infection that implicates ACE2 receptors, in conjunction with aldosterone and conditions that predispose to ARDS and poor disease outcome. ACE2 receptors are expressed by lung epithelial cells <ref type="bibr" target="#b33">[34]</ref>. The spike proteins of SARS-CoV bind to ACE2 receptors <ref type="bibr" target="#b55">[56,</ref><ref type="bibr" target="#b33">34,</ref><ref type="bibr" target="#b54">55]</ref>. Antibodies that bind ACE2 block SARS-CoV infection <ref type="bibr" target="#b33">[34]</ref>. "ACE2 has recently been identified as the SARS-CoV-2 receptor, the infective agent responsible for COVID-19, providing a critical link between immunity, inflammation, ACE2, and cardiovascular disease <ref type="bibr" target="#b56">[57]</ref>." "We know that SARS-COV-2 is bound to ACE2 which serves as a portal of entry of the SARS-COV2 virus into cells-just as it was for the SARS and probably the MERS viruses. Theoretically, anything with increased ACE2 levels could make patients more susceptible to infection with coronavirus, and make their cases more severe <ref type="bibr" target="#b57">[58]</ref>." "It is becoming evident that the RAAS system is involved in HCoV infections and presumably of high importance for their pathogenicity <ref type="bibr" target="#b33">[34]</ref>." "Attention shouldâ€¦ focus on monitoring COVID19 propensities for the â€¦diseases or treatments that trigger ACE2 increase <ref type="bibr" target="#b54">[55]</ref>."</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Infection creates a hypotonic challenge</head><p>During infection, monocytes and macrophages secrete cytokines, including tumor necrosis factor-alpha (TNF-alpha), interleukin-1beta (IL1B) and interleukin-6 (IL6), into the circulation <ref type="bibr" target="#b58">[59]</ref>. Increased plasma TNF-alpha, IL1B and IL6 stimulate secretion of corticotrophinreleasing hormone, adrenocorticotropic hormone, vasopressin and oxytocin <ref type="bibr" target="#b59">[60,</ref><ref type="bibr" target="#b60">61]</ref>, which trigger antidiuresis and increase risk of hyponatremia <ref type="bibr" target="#b58">[59]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Suboptimal hydration promotes an immune response like that described as a 'cytokine storm'</head><p>Preliminary data on COVID-19 and similarities between SARS-COV2 and other betacoronaviruses such as Severe Acute Respiratory Syndrome (SARS)-CoV or Middle East Respiratory Syndrome (MERS)-CoV suggest a 2-step pattern of activation of the immune system <ref type="bibr" target="#b61">[62]</ref>. During the type 1 IFN mediated initial step, in lung epithelial cells and macrophages, cascades of molecular events, via transcription factor nuclear factor ÎºB (NF-ÎºB) and IRF3/7, result in the production of cytokines such as IL1, IL6, or TNF-alpha. In some cases, the virus escapes the initial step, causing extra tissue damage and antibody response, which escalate subsequent immune response to the level of vicious cycle called cytokine storm <ref type="bibr" target="#b61">[62]</ref>; Additional, blood-derived macrophages/monocytes are attracted, activated and lead to uncontrolled, secondary innate and adaptive (T cell mediated) responses <ref type="bibr" target="#b61">[62]</ref>.</p><p>Chronic hypertonicity in the weeks before infection could conceivably play a role in suppressing the initial immune response to COVID-19 by lung epithelial cells. In vitro, treatment of primary human small airway epithelial cells with hypertonic saline suppresses neutrophil, monocyte, and natural killer and T cell chemoattractants, as well as the pro-inflammatory cytokines IL32, IL6 and LIF <ref type="bibr" target="#b25">[26]</ref>. Adaptation to chronic hypertonicity before infection may delay the arrival of neutrophils, monocytes, natural killer and T cells in the early stage of infection, allowing time for the COVID-19 virus to replicate and infect more cells.</p><p>Hypertonicity is described as a "danger signal" that boosts the immune system to ward off infection without need for de novo production of mediators <ref type="bibr" target="#b62">[63]</ref>. Hypertonicity may amplify neutrophil, monocyte, macrophage, and T cell response. Under the controlled environmental conditions of an enclosed spaceflight simulation center, compared to a lower salt diet of 6 g/d, a high salt diet of 12 g/d for 50 +/-10 days is associated with a marked increase in the number of monocytes and "potential risk of excessive immune response when infection occurs" in healthy young men <ref type="bibr" target="#b63">[64]</ref>. In a randomized, double-blind crossover study involving asthmatic patients, high salt diet for two weeks significantly increased post-exercise-induced sputum neutrophil and eosinophil differential cell counts and induced sputum supernatant concentration of eosinophil cationic protein, IL1beta, IL8, leukotriene (LT) C( <ref type="formula">4</ref>)-E(4), LTB(4), and prostaglandin D(2) compared to low salt diet <ref type="bibr" target="#b64">[65]</ref>. Adaptation to long-term or chronic hypertonicity may be required to magnify the immune response, as acute infusion of hypertonic saline does not significantly change the number of monocytes in young women <ref type="bibr" target="#b65">[66]</ref>. Effects of hypertonicity on immunity depend on the extent and duration of the hypertonic state <ref type="bibr" target="#b66">[67]</ref>.</p><p>Effects of hypertonicity on neutrophils, T cells and macrophages in vitro and in animal models have been reviewed by KÃ¸lsen-Petersen <ref type="bibr" target="#b66">[67]</ref>. Chronic hypertonicity impacts immune responses via signal transduction cascades that involve NF-ÎºB, p38 MAPK and NFAT5. NFAT5 coordinates expression of osmolytes <ref type="bibr" target="#b32">[33]</ref> and augments the effect of NF-ÎºB on critical aspects of the innate and adaptive immune responses <ref type="bibr" target="#b67">[68]</ref>.</p><p>In vitro, hypertonicity stimulates the secretion of pro-inflammatory cytokines such as IL6 and TNF-alpha by monocytes and induces the stimulation of macrophages <ref type="bibr" target="#b68">[69]</ref><ref type="bibr" target="#b69">[70]</ref><ref type="bibr" target="#b70">[71]</ref><ref type="bibr" target="#b71">[72]</ref>. Monocytes that produce extra TNF-alpha are distinguished as an "inflammatory subset" with potent pro-inflammatory activity <ref type="bibr" target="#b72">[73]</ref>. TNF-alpha induces NF-ÎºB, thereby creating a feedback system that propagates and magnifies cytokine response <ref type="bibr" target="#b67">[68]</ref>.</p><p>Increased extracellular osmolality also influences adaptive immunity. Hypertonic saline promotes T cell proliferation by increasing cAMP, which triggers a phosphorylation cascade that activates p38 MAPK in T cells, neutrophils, and monocytes <ref type="bibr" target="#b73">[74,</ref><ref type="bibr" target="#b74">75]</ref>, which in turn increases IL2 production. In T cells, hypertonic conditions activate NFAT5, which upregulates TNF-alpha alongside increased expression of osmoprotective genes <ref type="bibr" target="#b75">[76]</ref>. High salt conditions promote the differentiation of CD4 + helper T cells into IL17-producing CD4 + helper T cells (TH17 cells), via p38 MAPK and NFAT5 <ref type="bibr" target="#b76">[77]</ref>, as well as serum/ glucocorticoid-regulated kinase 1 (SGK1)-dependent signaling <ref type="bibr" target="#b77">[78,</ref><ref type="bibr" target="#b78">79]</ref>. In vitro hypertonicity or in vivo high salt diet also impair the function of regulatory T cells (Tregs), that normally counteract the effects of Th17 cells, by increasing the SGK1-mediated production of interferon gamma and inducing a TH1 phenotype (TH1-like Tregs) <ref type="bibr" target="#b79">[80]</ref>. Th17 cells are involved in inflammation and drive autoimmune diseases in animal models <ref type="bibr" target="#b78">[79]</ref>. Induced activation of Th17 cells results in ARDS in mice <ref type="bibr" target="#b80">[81]</ref>.</p><p>Regarding humoral immunity, hypertonicity participates in B cell activation and differentiation (Pax5 downregulation and CD138 upregulation) <ref type="bibr" target="#b81">[82]</ref>. In a secondary phase, it increases cell death and impairs plasmablast differentiation. Class switch to IgG1 is impaired, phosphorylation of p38 mitogen-activated kinase is inhibited and NFAT5 response is delayed.</p><p>Hypovolemia, in the context of large loss of blood volume due to hemorrhage, is known to trigger the immune system and increase inflammation <ref type="bibr" target="#b82">[83]</ref> and neutrophil activation <ref type="bibr" target="#b83">[84]</ref>. Effects of hemorrhagic shock (hypovolemia) on immune response are similar enough to those of hyperosmotic stress to be considered equivalent <ref type="bibr" target="#b84">[85]</ref>.</p><p>Finally, perhaps to balance or compensate for hypertonicity-induced increases in reactive oxygen species, and important when considering the context of infection-induced hypotonic challenge subsequent to adaptation to hypertonicity, chronic hypertonicity also increases intracellular glutathione, an antioxidant, via glutathione peroxidase (GPX) <ref type="bibr" target="#b80">[81]</ref>. Increased glutathione concentrations can restore redox balance and decrease the release of cytokines and chemokines from lung cells by decreasing NF-ÎºB activation <ref type="bibr" target="#b85">[86,</ref><ref type="bibr" target="#b86">87]</ref>. The main function of endogenous intracellular glutathione is to gauge the innate immune response to infection <ref type="bibr" target="#b87">[88]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Response to hypotonicity after adaptation to hypertonicity</head><p>Relative hypotonicity causes cell swelling by osmosis, which triggers cellular loss of organic osmolytes including amino acids, polyols and trimethylamines. Glutathione, a low molecular weight osmolyte and the most abundant intracellular antioxidant thiol, is depleted from cells in hyponatremia. The osmotically induced loss of intracellular glutathione makes cells more susceptible to oxidative injury <ref type="bibr" target="#b88">[89]</ref>. Glutathione production via glutathione peroxidase (GPX) is decreased by hypotonicity, delaying re-accumulation of intracellular glutathione concentrations after loss due to hypotonic swelling <ref type="bibr" target="#b88">[89]</ref>. An altered redox balance, excess generation vs. elimination of reactive oxygen species (ROS), is implicated in lung inflammation and ARDS <ref type="bibr" target="#b89">[90,</ref><ref type="bibr" target="#b90">91]</ref>.</p><p>During lung injury, in the midst of the hypotonic challenge, hypertonic saline has an anti-inflammatory effect. During injury, hypertonicity promotes cell cycle arrest, and prevents ROS formation and mitochondria depolarization, mediated by p53-p21 signaling <ref type="bibr" target="#b91">[92]</ref>. This effect implies the converse, that relative hypotonicity during the inflammatory response decreases p53 gene regulation and cell cycle arrest and increases ROS formation and mitochondrial polarization. It is well established that the use of isotonic saline to restore blood volume and tissue perfusion after hemorrhagic shock results in edema formation, neutrophil activation and an inflammatory cascade <ref type="bibr" target="#b80">[81]</ref>. For individuals who are adapted to hypertonic conditions, it would not be surprising that restoration of hypertonic conditions with hypertonic saline has beneficial effects.</p><p>Neutrophils are primary mediators of organ injury following trauma. The effect of hypertonicity on neutrophil activation depends on the timing of the hypertonicity <ref type="bibr" target="#b66">[67]</ref>. In vitro, it has been observed that if hypertonic saline is present before infection (lipopolysaccharide stimulation), then hypertonic solutions inhibit neutrophil activation in response to the infection <ref type="bibr" target="#b84">[85,</ref><ref type="bibr" target="#b73">74]</ref>. After hypertonic conditioning, neutrophils have an exaggerated cytotoxic response in normotonic conditions. In vitro, the duration of hypertonic pretreatment modifies lung neutrophil responsiveness to infection under isotonic conditions <ref type="bibr" target="#b92">[93]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Suboptimal hydration increases risk of fluid leakage into the airway space</head><p>Chronic hypertonicity and hypovolemia favor capillary leakage by increasing expression of VEGF, which stimulates lymphatic formation and endothelial nitric oxide synthase expression <ref type="bibr" target="#b36">[37,</ref><ref type="bibr" target="#b37">38]</ref>. Increased expression of VEGF stimulates angiogenesis and can increase vascular permeability 20,000 times more potently than histamine <ref type="bibr" target="#b93">[94,</ref><ref type="bibr" target="#b94">95]</ref>. It causes vasodilation, mediated by nitric oxide <ref type="bibr" target="#b95">[96,</ref><ref type="bibr" target="#b96">97]</ref>.</p><p>VEGF dysregulation is associated with ARDS <ref type="bibr" target="#b97">[98]</ref><ref type="bibr" target="#b98">[99]</ref><ref type="bibr" target="#b99">[100]</ref>. In mice, experimental overexpression of VEGF in alveolar epithelial cells is associated with capillary leakage and pulmonary edema <ref type="bibr" target="#b98">[99]</ref>, airway hyperresponsiveness, inflammation and mortality <ref type="bibr" target="#b96">[97]</ref>. Clinical studies report that ARDS patients have significantly higher plasma VEGF than normal controls and ventilated controls <ref type="bibr" target="#b97">[98]</ref>. Experimental data suggest that increases in plasma VEGF levels during infection determine ARDS risk. Following induced infection, mice that develop acute lung injury experience a significant increase in plasma VEGF levels by day 7 after infection, while mice that do not develop acute lung injury experience no significant change in VEGF levels <ref type="bibr" target="#b99">[100]</ref>.</p><p>Both pre-infection hypertonicity and infection-induced hypotonicity might be expected to increase plasma VEGF, because both hypernatremia and hypotonicity-induced aldosterone may increase VEGF. Aldosterone increases VEGF-A mRNA and protein expression in a doseand time-dependent manner in neutrophils via PI3 kinases, ERK1/2, and p38 MAPK <ref type="bibr">[148]</ref>. Angiogenesis is subject to U-shaped response curves <ref type="bibr">[151]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Suboptimal hydration limits active transport of fluid out of the airway space</head><p>Chronic hypertonicity and hypovolemia may limit active transport of fluid out of the lungs during COVID-19 infection by decreasing the expression of ENaC and Na + ,K +-ATPase. Fluid is normally removed from the alveolar space by active transport of sodium <ref type="bibr" target="#b24">[25]</ref> by Na + channels on the apical surface of the alveolar epithelium, and subsequently pumped out of the cell to the interstitium by Na + /K + -ATPase on the basal-lateral side <ref type="bibr">[152]</ref>. The sodium potassium adenosine triphospatase (Na + /K + -ATPase) on the basolateral surface of alveolar type 1 epithelia creates a driving force that pulls Na + from the alveolar space through the epithelial sodium channel (ENaC) and other amiloride sensitive sodium channels on the apical surface <ref type="bibr">[153]</ref>.</p><p>Active transport of sodium is impaired in ARDS <ref type="bibr" target="#b100">[101]</ref>. Dysregulation of the ion channels in alveolar epithelia cells causes pulmonary edema <ref type="bibr" target="#b101">[102]</ref>. Impaired ENaC predisposes to more severe lung injury <ref type="bibr" target="#b102">[103,</ref><ref type="bibr" target="#b103">104]</ref>. A 50% reduction in both alpha1 and alpha 2 subunit protein expression of ENaC significantly decreases the maximal cAMP dependent fluid clearance <ref type="bibr" target="#b104">[105]</ref>. Recovery from pulmonary edema depends on active salt and water fluid transport from the distal air spaces. Increased ENaC and Na + /K + -ATPase activity can reduce the risk of acute lung injury <ref type="bibr" target="#b105">[106]</ref><ref type="bibr" target="#b106">[107]</ref><ref type="bibr" target="#b107">[108]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Suboptimal hydration limits passive transport of fluid out of the airway space</head><p>Chronic hypertonicity and hypovolemia may limit passive transport of fluid out of the lungs during COVID-19 infection by causing an exaggerated decrease in the membrane abundance of aquaporin 5 (AQP5) water channels in response to the hypotonic challenge created by the infection.</p><p>AQP5 abundance is tightly regulated by osmolality and reduced in a stepwise fashion by extracellular hypotonicity <ref type="bibr" target="#b108">[109]</ref>. Cell responses to initial osmotic challenge and subsequent regulatory volume change require AQP5 <ref type="bibr" target="#b109">[110]</ref>. In individuals who are adapted to chronic hypertonicity before infection, the hypotonic conditions created during infection can be expected to represent a relatively more hypotonic challenge, resulting in an exaggerated reduction of AQP5 membrane abundance, compared to the response of individuals adapted to normotonic conditions before infection (See section on preliminary data and Appendix below). Downregulation of AQP5 decreases survival from sepsis induced lung injury <ref type="bibr" target="#b110">[111]</ref>.</p><p>In rats, pulmonary expression of AQP1 and AQP5 is downregulated by hypovolemia, induced by acute hemorrhage, and lipopolysaccharide infection <ref type="bibr" target="#b111">[112]</ref>. The "decrease in both AQP1 and AQP5 may contribute to edema by essentially reducing the transcellular rate of removal of excess water, thereby effectively trapping water in the alveolar and interstitial spaces. These changes in AQP expressions either may represent a response to inflammation associated pulmonary edema or may be causal in the formation of pulmonary edema <ref type="bibr" target="#b111">[112]</ref>".</p><p>In mice, pulmonary inflammation induced by adenovirus infection and lipopolysaccharide significantly downregulates AQP5 expression <ref type="bibr" target="#b112">[113,</ref><ref type="bibr" target="#b113">114]</ref>. Treatment of murine lung epithelial cells (MLE-12) with the proinflammatory cytokine TNF-alpha results in a concentration-and time-dependent decrease in AQP5 mRNA and protein expression <ref type="bibr" target="#b114">[115]</ref>. AQP5 expression is decreased 2-fold at the mRNA level and 10-fold at the protein level <ref type="bibr" target="#b114">[115]</ref>. The decreased AQP5 expression is sustained 7-14 days after infection. The molecular pathway for the AQP5 downregulation involves TNF-alpha binding to a 55-kDa receptor (TNFR1) and/or to a 75-kDa receptor (TNFR2) <ref type="bibr" target="#b114">[115,</ref><ref type="bibr" target="#b115">116]</ref>, alterations in gene expression via activation of multiple signal transduction pathways, including the MAP kinase family, ERK1/2, p38, and JNK <ref type="bibr" target="#b116">[117]</ref>, and NF-ÎºB <ref type="bibr" target="#b117">[118,</ref><ref type="bibr" target="#b115">116]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Intervention to address hydration status increases survival</head><p>Experimental data indicate that intervention to improve hydration reduces ARDS mortality <ref type="bibr" target="#b118">[119]</ref>. Under conditions of hemorrhage and shock, hypertonic resuscitation solutions cause a high osmotic gradient that shifts water into the intravascular compartment from edematous endothelial cells, an immediate increase of systemic pressure and cardiac output with reduced peripheral vascular resistance, instantaneous increase of blood flow, resumption of organ function, increased urinary output, and increased survival rate <ref type="bibr" target="#b118">[119]</ref>. Hypertonic saline resuscitation inhibits LPS-induced TNF-alpha production, enhances IL10 release, and shifts the balance of pro-and counter-inflammatory cytokine production in favor of an anti-inflammatory response in alveolar macrophages <ref type="bibr" target="#b120">[120]</ref>. Nebulized hypertonic saline decreases lung inflammation, alveolar macrophage activation, and neutrophil recruitment into the lung <ref type="bibr" target="#b121">[121]</ref>. In ARDS, a negative cumulative fluid balance is associated with markedly increased survival <ref type="bibr" target="#b6">[7,</ref><ref type="bibr" target="#b122">122,</ref><ref type="bibr" target="#b123">123]</ref>.</p><p>A large clinical network established through the National Heart, Lung and Blood Institute (NHLBI) developed fluid management guidelines that have improved outcomes for patients with ARDS <ref type="bibr" target="#b124">[124]</ref>. Consistent with a return to a pre-infection hypertonic state, hypertonic saline, and not isotonic saline, improves outcomes for ARDS patients <ref type="bibr" target="#b123">[123]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Alternative hypotheses</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Genetic predisposition</head><p>Genetic susceptibility to COVID-19 cannot be ruled out as an explanation for increased COVID-19 mortality that is independent of hydration. A polymorphism that affects ACE activity is associated, for example, with ARDS mortality. ARDS patients with genotype leading to lower ACE activity have increased survival <ref type="bibr" target="#b125">[125,</ref><ref type="bibr" target="#b126">126]</ref>. A common single nucleotide polymorphism (SNP; -1364A/C; rs3759129) in the AQP5 gene promoter, cytosine instead of adenosine at position -1364, is associated with decreased AQP5 expression <ref type="bibr" target="#b127">[127]</ref> and decreased survival from sepsis <ref type="bibr" target="#b128">[128]</ref>. A gain-of-function SGK1 polymorphism could cause metabolic syndrome on the one hand and augment the inflammatory response during COVID-19 induced ARDS on the other <ref type="bibr" target="#b129">[129]</ref> </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Implications of the hypothesized mechanism</head><p>The hypothesized mechanism(s) described above suggest opportunity for hydration-related strategies to limit COVID-19 mortality and motivate testable hypotheses regarding hydration screening to identify people at-risk, drinking water intervention to reduce COVID-19 infection and morbidity, and treatment protocol tailored to the pre-infection hydration condition.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Potential for hydration screening to identify people at-risk</head><p>Despite lack of a gold standard biomarker for hydration <ref type="bibr" target="#b130">[130]</ref> and controversy regarding chronic TBW deficit among non-acutely ill individuals under free-living conditions <ref type="bibr" target="#b30">[31]</ref>, biomarkers such as leukocyte SGK1 mRNA and saliva osmolality, at the cellular and physiological levels, respectively, may reflect chronic hypertonicity and/or TBW deficit and increased risk of COVID-19 infection, morbidity and/or mortality.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Sgk1</head><p>SGK1 is strongly upregulated by dehydration <ref type="bibr" target="#b129">[129]</ref> and contributes to the orchestration of inflammation <ref type="bibr" target="#b131">[131]</ref>. SGK1 stimulates IL23 <ref type="bibr" target="#b77">[78]</ref> to generate IL17-producing CD4 + TH17 cells <ref type="bibr" target="#b78">[79]</ref>. TH17 cells, in turn, upregulate the pro-inflammatory cytokines GM-CSF, TNF-alpha and IL2 <ref type="bibr" target="#b78">[79]</ref>. Up-regulation of SGK1 theoretically predisposes to a severe course of lung infection.</p><p>SGK1 participates in the orchestration of tissue fibrosis, by inactivating the ubiquitin ligase Nedd4L, which degrades TGFÃŸ, a key stimulator of fibrosis <ref type="bibr" target="#b132">[132]</ref>. SGK1 activates NFÎºB <ref type="bibr" target="#b133">[133]</ref>, a transcription factor fostering inflammation and fibrosis <ref type="bibr" target="#b132">[132,</ref><ref type="bibr" target="#b134">134,</ref><ref type="bibr" target="#b135">135]</ref>. Excessive SGK1 expression is observed in a wide variety of fibrosing diseases, including lung fibrosis <ref type="bibr" target="#b132">[132,</ref><ref type="bibr" target="#b133">133,</ref><ref type="bibr" target="#b136">136,</ref><ref type="bibr" target="#b137">137]</ref>.</p><p>SGK1 plays a pivotal role in platelet activation <ref type="bibr" target="#b129">[129]</ref>, which contributes to a severe course of COVID-19 infection <ref type="bibr" target="#b138">[138]</ref> </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Saliva osmolality</head><p>Saliva osmolality has been proposed as a biomarker for isotonic dehydration <ref type="bibr" target="#b139">[139]</ref> and chronic TBW deficit <ref type="bibr" target="#b30">[31]</ref>. Unlike serum and urine osmolality, which are sensitive to acute change in TBW <ref type="bibr" target="#b140">[140,</ref><ref type="bibr" target="#b141">141,</ref><ref type="bibr" target="#b142">142]</ref>, saliva osmolality appears relatively more sensitive to longer-term hydration, over weeks, than serum or urine osmolality <ref type="bibr" target="#b30">[31]</ref> (See preliminary data and Appendix below). Saliva osmolality is regulated by aldosterone <ref type="bibr" target="#b143">[143,</ref><ref type="bibr" target="#b144">144]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Potential for drinking water intervention</head><p>As of August 2020, health authorities, including the WHO [145] and CDC <ref type="bibr" target="#b145">[146]</ref>, advise the public to wash hands often with soap and water, avoid touching the face, avoid close contact with people by physical distancing and staying home, wear mouth covering around others, and regularly clean and disinfect. None of the recommended strategies explicitly work to correct chronic hypertonicity and/or hypovolemia. Prospective studies and randomized interventions might test if, in addition to sheltering in place, a sustained increase in drinking water over weeks lowers COVID-19 mortality to a greater extent than social distancing alone, by decreasing ACE2 receptors and improving immune response.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Preliminary data regarding effects of drinking water intervention</head><p>In healthy young men under conditions of daily life, sustaining an increase in total water intake from a baseline below 2L/d to above 3L/d for 4 weeks by increasing intake of plain drinking water was associated with significant increases in plasma aldosterone <ref type="bibr" target="#b30">[31]</ref> and VEGF, and a smaller reduction in saliva AQP5 following acute hypotonic challenge (See Appendix). At baseline, 60 min after an acute bolus of 750 ml drinking water following overnight food and water restriction, the mean (SE) saliva AQP5 was 0.20 (0.09) ng/ml. After 4 weeks of sustained higher water intake, the corresponding post-bolus mean (SE) saliva AQP5 was higher, 0.87 (0.43) ng/ml.</p><p>The preliminary data also suggest that for individuals with usual total water intake below 2L/d and urine osmolality above 800 ml/kg, saliva osmolality above 100 mmol/kg (i.e. indication of TBW deficit in addition to hypertonicity) signals different response to drinking water intervention. After 4 weeks of consuming &gt; +1L/d drinking water above baseline, individuals who initially have urine osmolality above 800 mmol/kg and saliva osmolality above 100 ml/kg show significantly greater increases in RBC glutathione peroxidase and RBC K:Na after a 750 ml bolus of drinking water than individuals with initial saliva osmolality below 100 mmol/kg (see Appendix).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Potential to tailor treatment for COVID-19 to pre-infection hydration status</head><p>Although "fluid management is important to consider as a measure to reduce pulmonary oedema <ref type="bibr" target="#b12">[13]</ref>", treatment guidelines do not call attention to the pre-infection chronic hydration state. The guidelines focus on the acute hydration state during infection: "In the absence of shock, fluid conservative therapy is recommended to achieve a negative fluid balance of 0.5-1.0 L per day. In the presence of shock, fluid balance might be achieved with renal replacement therapy, especially if there is associated acute kidney injury and oliguria <ref type="bibr" target="#b12">[13]</ref>." "Therapeutically, hyponatremia during inflammation is challenging. However, it is important for physicians to beware of the predisposition to anti-diuresis in this context and adjust intravenous fluid therapy accordingly <ref type="bibr" target="#b58">[59]</ref>."</p><p>Treatment tailored to pre-infection hydration state is hampered by the fact that lab tests ordered when the patient presents to the clinic reflect status after infection. Recognized hydration lab tests such as urine osmolality, BUN:creatinine and serum osmolality are relatively insensitive to chronic hypertonicity over weeks before the infection. There is potential opportunity to add biomarkers of chronic hypertonicity, such as SGK1 and saliva osmolality, to clinical lab protocol.</p><p>Wevers et al <ref type="bibr" target="#b33">[34]</ref> suggest that if the pathogenicity of coronavirus infections depends on dysregulation of the renin-aldosterone system, then "a therapy aimed at restoring the RAS equilibrium provides the opportunity to treat the symptoms of an infection. Especially in elderly patients, this treatment might be beneficial as the aged population is most vulnerable to deregulation of the RAS."</p><p>Chiusano et al <ref type="bibr" target="#b54">[55]</ref> hypothesize that the severity of COVID-19 infection is modulated by patient predisposition and capability to mount an appropriate immune response before infection.</p><p>The success of hypertonic saline treatment may depend on preexisting dehydration <ref type="bibr" target="#b80">[81,</ref><ref type="bibr" target="#b146">147]</ref>.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0"><graphic coords="3,126.14,56.98,342.96,155.28" type="bitmap" /></figure>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Summary</head><p>In sum, this paper hypothesizes that sub-optimal hydration in the weeks prior to exposure to COVID-19 increases risk of COVID-19 mortality via multiple possible pathways that favor fluid accumulation in the lungs. Evidence from in-vitro, animal, clinical and epidemiological studies suggest that chronic plasma hypertonicity, TBW deficit and/or hypovolemia may increase the likelihood of COVID-19 infection, pre-set the body for exaggerated immune response, increase tissue damage and leakage of fluid into the airway space, and/or decrease capacity for active and passive transport of fluid out of the airway space.</p><p>Taken together, the evidence suggests that strategies to limit COVID-19 mortality may need to account for multiple determinants of water retention, fluid entry into and fluid removal out of the lungs, simultaneously. The mechanism(s) described above suggest testable hypotheses regarding screening to identify at-risk groups, public health recommendations to limit risk, and clinical treatment protocol. The preinfection hydration condition is measurable by biomarkers and modifiable by drinking water. The United Nations imperative to have drinking water be available and accessible, worldwide [148], might be leveraged for COVID-19 risk reduction. Attention to hydration by clinicians, researchers and public health authorities has potential to block at least 5 pathways to COVID morbidity and holds promise to prevent death due to COVID-19.</p><p>Grant support None.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conflict of interest</head><p>In the past five years, J.D.S. and F.L. have provided consultant support to Danone Research. Authorship J.D.S conceived of this manuscript and drafted and finalized all sections. D.C. drafted the section regarding hypertonicity effects on immunity and reviewed the manuscript. P.K.R.A. and D.P. completed the SGK1 assays for the Adapt Study, drafted sections related to those results, and reviewed the manuscript. F.L. drafted the section regarding SGK1 and reviewed the manuscript. Appendix 1. Biomarkers of status at baseline and change associated with 4 weeks of sustained higher drinking water in 5 healthy young men with initial total water intake below 2L/d who participated in the Adapt study. The Adapt study aims, pre-post design, data collection protocol and methods for determining saliva osmolality, RBC K:Na, half-life of water in the body and body weight change are described elsewhere <ref type="bibr" target="#b31">[32,</ref><ref type="bibr" target="#b30">31]</ref>. After a baseline period, the Adapt study induced increases in drinking water of 1L/d or more above baseline, which were sustained for 4 weeks. Saliva, blood and body weight were measured each week. Each week, saliva and blood were collected 60 min after a 750 ml bolus of drinking water following overnight food and water restriction. The saliva and blood results in this table thus reflect status in the hour after an acute hypotonic challenge, at baseline and after 4 weeks of sustained higher water intake. SGK1: Human SGK1 gene expression analysis by qPCR. Total RNA from human whole blood was isolated using PAXgene Blood miRNA extraction kit, according to the manufacturer's instructions. RNA concentrations were estimated by Nanodrop. Equal amounts of RNA were retro-transcribed to cDNA using cDNA synthesis kit (Bio-Rad). The resultant cDNA was used as template in quantitative PCR reactions containing SYBR-green fluorescent dye (Bio-Rad). Human SGK1 relative expression levels were calculated using the 2^-delta Ct method. Human actin (hActin) expression was used for SGK1 normalization. Target primer (5â€²-3â€²) sequences for SGK1 were TTC TCT TTC CAG ACT GCT GA and TGG ATG TTG TGC TGT </p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<monogr>
		<ptr target="https://www.cbsnews.com/news/coronavirus-infection-outbreak-worldwide-virus-expert-warning-today-2020-03-02/" />
		<title level="m">Coronavirus may infect up to 70% of world&apos;s population, expert warns -CBS News</title>
		<imprint>
			<date type="published" when="2020-04-28">April 28, 2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<monogr>
		<ptr target="https://www.vox.com/coronavirus-covid19/2020/3/27/21193879/coronavirus-covid-19-social-distancing-economy-recession-depression" />
		<title level="m">Trump&apos;s plan to end coronavirus social distancing has sparked a major debate -Vox n</title>
		<imprint>
			<date type="published" when="2020-04-28">April 28, 2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<monogr>
		<ptr target="https://www.nytimes.com/2020/04/12/us/politics/coronavirus-poverty-privacy.html" />
		<title level="m">The Coronavirus Class Divide: Space and Privacy -The New York Times</title>
		<imprint>
			<date type="published" when="2020-05-08">May 8, 2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<monogr>
		<ptr target="https://www.nbcsandiego.com/news/investigations/there-are-300-available-ventilators-in-san-diego-county-is-that-enough/2291581/" />
		<title level="m">There are 300 Available Ventilators in San Diego County: Is That Enough? -NBC 7 San Diego n</title>
		<imprint>
			<date type="published" when="2020-04-28">April 28, 2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<monogr>
		<ptr target="https://www.click2houston.com/features/2020/03/30/what-damage-does-covid-19-do-to-your-lungs/" />
		<title level="m">What damage does COVID-19 do to your lungs? n</title>
		<imprint>
			<date type="published" when="2020-04-28">April 28, 2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<monogr>
		<ptr target="https://www.nationalgeographic.com/science/2020/02/here-is-what-coronavirus-does-to-the-body/" />
		<title level="m">Here&apos;s what coronavirus does to the body n</title>
		<imprint>
			<date type="published" when="2020-04-28">April 28, 2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">The aquaporin 5-1364A/C promoter polymorphism impacts on resolution of acute kidney injury in pneumonia evoked ARDS</title>
		<author>
			<persName><forename type="first">T</forename><surname>Rahmel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Nowak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Rump</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Siffert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Peters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Adamzik</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0208582</idno>
		<ptr target="https://doi.org/10.1371/journal.pone.0208582" />
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page">208582</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) -United States</title>
		<author>
			<persName><forename type="first">S</forename><surname>Bialek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Boundy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Bowen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Chow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Cohn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Dowling</surname></persName>
		</author>
		<idno type="DOI">10.15585/mmwr.mm6912e2</idno>
		<ptr target="https://doi.org/10.15585/mmwr.mm6912e2" />
	</analytic>
	<monogr>
		<title level="j">MMWR Morb Mortal Wkly Rep</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="343" to="346" />
			<date type="published" when="2020-03-16">February 12-March 16, 2020. 2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<monogr>
		<ptr target="https://www.businessinsider.com/men-women-coronavirus-death-rates-by-country-worldwide-health-habits-2020-4" />
		<title level="m">Male vs female coronavirus deaths by country: Italy, China, Spain -Business Insider n</title>
		<imprint>
			<date type="published" when="2020-05-10">May 10, 2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<monogr>
		<ptr target="https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-at-higher-risk.html" />
		<title level="m">People Who Are at Higher Risk for Severe Illness|CDC n</title>
		<imprint>
			<date type="published" when="2020-04-28">April 28, 2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">COVID-19 and African Americans</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">W</forename><surname>Yancy</surname></persName>
		</author>
		<idno type="DOI">10.1001/jama.2020.6548</idno>
		<ptr target="https://doi.org/10.1001/jama.2020.6548" />
	</analytic>
	<monogr>
		<title level="j">JAMA</title>
		<imprint>
			<biblScope unit="volume">60611</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<monogr>
		<ptr target="https://www.apmresearchlab.org/covid/deaths-by-race" />
		<title level="m">COVID-19 deaths analyzed by race and ethnicity -APM Research Lab n</title>
		<imprint>
			<date type="published" when="2020-04-28">April 28, 2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Treatment for severe acute respiratory distress syndrome from COVID-19</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Matthay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Aldrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Gotts</surname></persName>
		</author>
		<idno type="DOI">10.1016/S2213-2600(20)30127-2</idno>
		<ptr target="https://doi.org/10.1016/S2213-2600(20)30127-2" />
	</analytic>
	<monogr>
		<title level="j">Lancet Respir Med</title>
		<imprint>
			<biblScope unit="volume">2600</biblScope>
			<biblScope unit="page" from="2019" to="2020" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Functional significance of cell volume regulatory mechanisms</title>
		<author>
			<persName><forename type="first">F</forename><surname>Lang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">L</forename><surname>Busch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ritter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>VÃ¶lkl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Waldegger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Gulbins</surname></persName>
		</author>
		<idno type="DOI">10.1152/physrev.1998.78.1.247</idno>
		<ptr target="https://doi.org/10.1152/physrev.1998.78.1.247" />
	</analytic>
	<monogr>
		<title level="j">Physiol Rev</title>
		<imprint>
			<biblScope unit="volume">78</biblScope>
			<biblScope unit="page" from="247" to="306" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Pulmonary edema</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">C</forename><surname>Staub</surname></persName>
		</author>
		<idno type="DOI">10.1152/physrev.1974.54.3.678</idno>
		<ptr target="https://doi.org/10.1152/physrev.1974.54.3.678" />
	</analytic>
	<monogr>
		<title level="j">Physiol Rev</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page" from="678" to="811" />
			<date type="published" when="1974">1974</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Alveolar edema fluid clearance and acute lung injury</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Berthiaume</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Matthay</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.resp.2007.05.010</idno>
		<ptr target="https://doi.org/10.1016/j.resp.2007.05.010" />
	</analytic>
	<monogr>
		<title level="j">Respir Physiol Neurobiol</title>
		<imprint>
			<biblScope unit="volume">159</biblScope>
			<biblScope unit="page" from="350" to="359" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">High prevalence of plasma hypertonicity among community-dwelling older adults: Results from NHANES III</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Stookey</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jada.2005.05.003</idno>
		<ptr target="https://doi.org/10.1016/j.jada.2005.05.003" />
	</analytic>
	<monogr>
		<title level="j">J Am Diet Assoc</title>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="page" from="1231" to="1239" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Underhydration is associated with obesity, chronic diseases, and death within 3 to 6 years in the u.S. population aged 51-70 years</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Stookey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kavouras</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Suh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Lang</surname></persName>
		</author>
		<idno type="DOI">10.3390/nu12040905</idno>
		<ptr target="https://doi.org/10.3390/nu12040905" />
	</analytic>
	<monogr>
		<title level="j">Nutrients</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Prevalence, incidence and etiology of hyponatremia in elderly patients with fragility fractures</title>
		<author>
			<persName><forename type="first">K</forename><surname>Cumming</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">E</forename><surname>Hoyle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Hutchison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Soiza</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0088272</idno>
		<ptr target="https://doi.org/10.1371/journal.pone.0088272" />
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">88272</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Elevated serum osmolality and total water deficit indicate impaired hydration status in residents of long-term care facilities regardless of low or high body mass index</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">V</forename><surname>Marra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">F</forename><surname>Simmons</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Shotwell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hudson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">K</forename><surname>Hollingsworth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Long</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jand.2015.12.011</idno>
		<ptr target="https://doi.org/10.1016/j.jand.2015.12.011" />
	</analytic>
	<monogr>
		<title level="j">J Acad Nutr Diet</title>
		<imprint>
			<biblScope unit="volume">116</biblScope>
			<biblScope unit="issue">828-836</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Sodium status and the metabolic syndrome: a systematic review and meta-analysis of observational studies</title>
		<author>
			<persName><forename type="first">S</forename><surname>Soltani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Kolahdouz</forename><surname>Mohammadi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Shab-Bidar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Vafa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Salehi-Abargouei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
		<idno type="DOI">10.1080/10408398.2017.1363710</idno>
		<ptr target="https://doi.org/10.1080/10408398.2017.1363710" />
	</analytic>
	<monogr>
		<title level="j">Crit Rev Food Sci Nutr</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="196" to="206" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Vasopressin and diabetic kidney disease</title>
		<author>
			<persName><forename type="first">El</forename><surname>Boustany</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename></persName>
		</author>
		<idno type="DOI">10.1159/000488124</idno>
		<ptr target="https://doi.org/10.1159/000488124" />
	</analytic>
	<monogr>
		<title level="j">Ann Nutr Metab</title>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="page" from="17" to="20" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<monogr>
		<ptr target="https://www.ncbi.nlm.nih.gov/pubmed/?term=Abhinav+Goyal%3B+Parnaz+Daneshpajouhnejad%3B+Muhammad+F" />
		<title level="m">Acute Kidney Injury (Acute Renal Failure</title>
		<imprint>
			<date type="published" when="2020-04-29">April 29, 2020</date>
		</imprint>
	</monogr>
	<note>+Hashmi%3B+Khalid+Bashir. +Acute+Kidney+Injury+</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Exercise-and cold-induced asthma</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">G</forename><surname>Giesbrecht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Younes</surname></persName>
		</author>
		<idno type="DOI">10.1139/h95-023</idno>
		<ptr target="https://doi.org/10.1139/h95-023" />
	</analytic>
	<monogr>
		<title level="j">Can J Appl Physiol</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="300" to="314" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Hyponatremia in cirrhosis: Pathophysiology and management</title>
		<author>
			<persName><forename type="first">S</forename><surname>John</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Thuluvath</surname></persName>
		</author>
		<idno type="DOI">10.3748/wjg.v21.i11.3197</idno>
		<ptr target="https://doi.org/10.3748/wjg.v21.i11.3197" />
	</analytic>
	<monogr>
		<title level="j">World J Gastroenterol</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="3197" to="3205" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia</title>
		<author>
			<persName><forename type="first">S</forename><surname>Mitra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Schiller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Gamboni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>'alessandro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kelher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0189536</idno>
		<ptr target="https://doi.org/10.1371/journal.pone.0189536" />
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="1" to="20" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Plasma hypertonicity: another marker of frailty?</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Stookey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Purser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">F</forename><surname>Pieper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Cohen</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1532-5415.2004.52361.x</idno>
		<ptr target="https://doi.org/10.1111/j.1532-5415.2004.52361.x" />
	</analytic>
	<monogr>
		<title level="j">J Am Geriatr Soc</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="1313" to="1320" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Regulation of cell volume in health and disease</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Mcmanus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">B</forename><surname>Churchwell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Strange</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">333</biblScope>
			<biblScope unit="page" from="1260" to="1266" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Osmotic homeostasis</title>
		<author>
			<persName><forename type="first">J</forename><surname>Danziger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Zeidel</surname></persName>
		</author>
		<idno type="DOI">10.2215/CJN.10741013</idno>
		<ptr target="https://doi.org/10.2215/CJN.10741013" />
	</analytic>
	<monogr>
		<title level="j">Clin J Am Soc Nephrol</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="852" to="862" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Living with water stress: evolution of osmolyte systems</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Yancey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Clark</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Hand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Bowlus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">N</forename><surname>Somero</surname></persName>
		</author>
		<idno type="DOI">10.1126/science.7112124</idno>
		<ptr target="https://doi.org/10.1126/science.7112124" />
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">80</biblScope>
			<biblScope unit="page" from="1214" to="1222" />
			<date type="published" when="1982">1982</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Change in hydration indices associated with an increase in total water intake of more than 0.5 l/day, sustained over 4 weeks, in healthy young men with initial total water intake below 2 L/day</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Stookey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hamer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">W</forename><surname>Killilea</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Physiol Rep</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="1" to="22" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">RBC deformability and amino acid concentrations after hypo-osmotic challenge may reflect chronic cell hydration status in healthy young men</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Stookey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Klein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hamer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Chi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Higa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Ng</surname></persName>
		</author>
		<idno type="DOI">10.1002/phy2.117</idno>
		<ptr target="https://doi.org/10.1002/phy2.117" />
	</analytic>
	<monogr>
		<title level="j">Physiol Rep</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<monogr>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Maldonado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Mohiuddin</surname></persName>
		</author>
		<title level="m">Biochemistry. Hypertonicity</title>
		<imprint>
			<publisher>StatPearls Publishing</publisher>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Renin-angiotensin system in human coronavirus pathogenesis</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Wevers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Van</forename><surname>Der Hoek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename></persName>
		</author>
		<idno type="DOI">10.2217/fvl.10.4</idno>
		<ptr target="https://doi.org/10.2217/fvl.10.4" />
	</analytic>
	<monogr>
		<title level="j">Future Virol</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="145" to="161" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Differential sympathetic and angiotensinergic responses in rats submitted to lowor high-salt diet</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Carillo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Beutel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Mirandola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Vidonho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Lns</forename><surname>Furukawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Casarini</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.regpep.2006.11.007</idno>
		<ptr target="https://doi.org/10.1016/j.regpep.2006.11.007" />
	</analytic>
	<monogr>
		<title level="j">Regul Pept</title>
		<imprint>
			<biblScope unit="volume">140</biblScope>
			<biblScope unit="page" from="5" to="11" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Osmotic stress regulates mineralocorticoid receptor expression in a novel aldosterone-sensitive cortical collecting duct cell line</title>
		<author>
			<persName><forename type="first">S</forename><surname>Viengchareun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Kamenicky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Teixeira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Butlen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Meduri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Blanchard-Gutton</surname></persName>
		</author>
		<idno type="DOI">10.1210/me.2009-0095</idno>
		<ptr target="https://doi.org/10.1210/me.2009-0095" />
	</analytic>
	<monogr>
		<title level="j">Mol Endocrinol</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="1948" to="1962" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Sodium sensing in the interstitium and relationship to hypertension</title>
		<author>
			<persName><forename type="first">J</forename><surname>Titze</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Machnik</surname></persName>
		</author>
		<idno type="DOI">10.1097/MNH.0b013e32833aeb3b</idno>
		<ptr target="https://doi.org/10.1097/MNH.0b013e32833aeb3b" />
	</analytic>
	<monogr>
		<title level="j">Curr Opin Nephrol Hypertens</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="385" to="392" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Immunolocalization of VEGF, VEGFR-1 and VEGFR-2 in lung tissues after acute hemorrhage in rats</title>
		<author>
			<persName><forename type="first">N</forename><surname>Ekerbicer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Tarakci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Barut</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Inan</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.acthis.2007.10.010</idno>
		<ptr target="https://doi.org/10.1016/j.acthis.2007.10.010" />
	</analytic>
	<monogr>
		<title level="j">Acta Histochem</title>
		<imprint>
			<biblScope unit="volume">110</biblScope>
			<biblScope unit="page" from="285" to="293" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Effect of cell hydration on metabolism</title>
		<author>
			<persName><forename type="first">F</forename><surname>Lang</surname></persName>
		</author>
		<idno type="DOI">10.1159/000329290</idno>
		<ptr target="https://doi.org/10.1159/000329290" />
	</analytic>
	<monogr>
		<title level="j">Nestle Nutr Inst Workshop Ser</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="115" to="126" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Aldosterone and the enhanced natriuresis of hypertonic infusions in the dog</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Childers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">G</forename><surname>Schneider</surname></persName>
		</author>
		<idno type="DOI">10.1152/ajprenal.1982.242.1.f30</idno>
		<ptr target="https://doi.org/10.1152/ajprenal.1982.242.1.f30" />
	</analytic>
	<monogr>
		<title level="j">Am J Physiol -Ren Fluid Electrolyte Physiol</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<date type="published" when="1982">1982</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Effect of plasma sodium on aldosterone secretion during angiotensin II stimulation in normal humans</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Merrill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Ebert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Skelton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">W</forename><surname>Cowley</surname></persName>
		</author>
		<idno type="DOI">10.1161/01.HYP.14.2.164</idno>
		<ptr target="https://doi.org/10.1161/01.HYP.14.2.164" />
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="164" to="169" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Effect of volume expansion with hypertonic-and isotonic saline and isotonic glucose on sodium and water transport in the principal cells in the kidney</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Jensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">H</forename><surname>Mose</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Bech</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Nielsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">B</forename><surname>Pedersen</surname></persName>
		</author>
		<idno type="DOI">10.1186/1471-2369-14-202</idno>
		<ptr target="https://doi.org/10.1186/1471-2369-14-202" />
	</analytic>
	<monogr>
		<title level="j">BMC Nephrol</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Effect of isotonic versus hypotonic maintenance fluid therapy on urine output, fluid balance, and electrolyte homeostasis: a crossover study in fasting adult volunteers</title>
		<author>
			<persName><forename type="first">N</forename><surname>Van Regenmortel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Weerdt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Van</forename><surname>Craenenbroeck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Roelant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Verbrugghe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Dams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename></persName>
		</author>
		<idno type="DOI">10.1093/bja/aex118</idno>
		<ptr target="https://doi.org/10.1093/bja/aex118" />
	</analytic>
	<monogr>
		<title level="j">Br J Anaesth</title>
		<imprint>
			<biblScope unit="volume">118</biblScope>
			<biblScope unit="page" from="892" to="900" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Osmotic stimulation of vasopressin acutely impairs glucose regulation: a counterbalanced, crossover trial</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">T</forename><surname>Jansen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Suh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Adams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Sprong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Seal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Scott</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">110</biblScope>
			<biblScope unit="page" from="1344" to="1352" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">A proposed method for assessing plasma hypertonicity in vivo</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Stookey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Burg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Sellmeyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Greenleaf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Arieff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Van Hove</surname></persName>
		</author>
		<idno type="DOI">10.1038/sj.ejcn.1602481</idno>
		<ptr target="https://doi.org/10.1038/sj.ejcn.1602481" />
	</analytic>
	<monogr>
		<title level="j">Eur J Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="page" from="143" to="146" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Extrasynaptic volume transmission and diffusion parameters of the extracellular space</title>
		<author>
			<persName><forename type="first">E</forename><surname>SykovÃ¡</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.neuroscience.2004.06.077</idno>
		<ptr target="https://doi.org/10.1016/j.neuroscience.2004.06.077" />
	</analytic>
	<monogr>
		<title level="j">Neuroscience</title>
		<imprint>
			<biblScope unit="volume">129</biblScope>
			<biblScope unit="page" from="861" to="876" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Volume-dependent osmolyte efflux from neural tissues: Regulation by G-protein-coupled receptors</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Fisher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Cheema</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Foster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Heacock</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1471-4159.2008.05510.x</idno>
		<ptr target="https://doi.org/10.1111/j.1471-4159.2008.05510.x" />
	</analytic>
	<monogr>
		<title level="j">J Neurochem</title>
		<imprint>
			<biblScope unit="volume">106</biblScope>
			<biblScope unit="page" from="1998" to="2014" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Osmolytes and mechanisms involved in regulatory volume decrease under conditions of sudden or gradual osmolarity decrease</title>
		<author>
			<persName><forename type="first">B</forename><surname>Ordaz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Tuz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">D</forename><surname>Ochoa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Lezama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>PeÃ±a-Segura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Franco</surname></persName>
		</author>
		<idno type="DOI">10.1023/b:nere.0000010434.06311.18</idno>
		<ptr target="https://doi.org/10.1023/b:nere.0000010434.06311.18" />
	</analytic>
	<monogr>
		<title level="j">Neurochem Res</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="65" to="72" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Impairment of insulin-mediated glucose metabolism by hyperosmolality in man</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">R</forename><surname>Bratusch Marrain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Defronzo</surname></persName>
		</author>
		<idno type="DOI">10.2337/diab.32.11.1028</idno>
		<ptr target="https://doi.org/10.2337/diab.32.11.1028" />
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="1028" to="1034" />
			<date type="published" when="1983">1983</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Aldosterone, but not angiotensin II, reduces angiotensin converting enzyme 2 gene expression levels in cultured neonatal rat cardiomyocytes</title>
		<author>
			<persName><forename type="first">M</forename><surname>Yamamuro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Yoshimura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Nakayama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Abe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Sumida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sugiyama</surname></persName>
		</author>
		<idno type="DOI">10.1253/circj.72.1346</idno>
		<ptr target="https://doi.org/10.1253/circj.72.1346" />
	</analytic>
	<monogr>
		<title level="j">Circ J</title>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="page" from="1346" to="1350" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Hyporeninemic hypoaldosteronism and diabetes mellitus: pathophysiology assumptions, clinical aspects and implications for management</title>
		<author>
			<persName><forename type="first">Agp</forename><surname>Sousa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">V</forename><surname>Cabral</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>De</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">B</forename><surname>El-Feghaly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>De Sousa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Nunes</surname></persName>
		</author>
		<idno type="DOI">10.4239/wjd.v7.i5.101</idno>
		<ptr target="https://doi.org/10.4239/wjd.v7.i5.101" />
	</analytic>
	<monogr>
		<title level="j">World J Diabetes</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">101</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Characterization of ACE and ACE2 expression within different organs of the NOD mouse</title>
		<author>
			<persName><forename type="first">H</forename><surname>Roca-Ho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Riera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Palau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Pascual</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Soler</surname></persName>
		</author>
		<idno type="DOI">10.3390/ijms18030563</idno>
		<ptr target="https://doi.org/10.3390/ijms18030563" />
	</analytic>
	<monogr>
		<title level="j">Int J Mol Sci</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">ACE and ACE2 activity in diabetic mice</title>
		<author>
			<persName><forename type="first">J</forename><surname>Wysocki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Soler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Gurley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">D</forename><surname>Xiao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Bernstein</surname></persName>
		</author>
		<idno type="DOI">10.2337/db06-0033</idno>
		<ptr target="https://doi.org/10.2337/db06-0033" />
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="2132" to="2139" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">COVID-19 pandemic, corona viruses, and diabetes mellitus</title>
		<author>
			<persName><forename type="first">R</forename><surname>Muniyappa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gubbi</surname></persName>
		</author>
		<idno type="DOI">10.1152/ajpendo.00124.2020</idno>
		<ptr target="https://doi.org/10.1152/ajpendo.00124.2020" />
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">318</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<monogr>
		<title level="m" type="main">The modelling of COVID19 pathways sheds light on mechanisms, opportunities and on controversial interpretations of medical treatments</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Chiusano</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2020">2020</date>
			<biblScope unit="volume">2</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Kidney disease is associated with in-hospital death of patients with COVID-19</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Luo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Dong</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.kint.2020.03.005</idno>
		<ptr target="https://doi.org/10.1016/j.kint.2020.03.005" />
	</analytic>
	<monogr>
		<title level="j">Kidney Int</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="page" from="829" to="838" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Angiotensin converting enzyme 2: SARS-CoV-2 receptor and regulator of the reninangiotensin system</title>
		<author>
			<persName><forename type="first">M</forename><surname>Gheblawi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Viveiros</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Nguyen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J-C</forename><surname>Zhong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Turner</surname></persName>
		</author>
		<idno type="DOI">10.1161/circresaha.120.317015</idno>
		<ptr target="https://doi.org/10.1161/circresaha.120.317015" />
	</analytic>
	<monogr>
		<title level="j">Circ Res</title>
		<imprint>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<monogr>
		<title level="m" type="main">ACE Inhibitors &amp; ARBs: Wading Into the Unknown of COVID-19</title>
		<author>
			<persName><forename type="first">Simon</forename><surname>Murray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
		<imprint>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Hyponatremia and inflammation: the emerging role of interleukin-6 in osmoregulation</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Swart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Hoorn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Betjes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Zietse</surname></persName>
		</author>
		<idno type="DOI">10.1159/000322238</idno>
		<ptr target="https://doi.org/10.1159/000322238" />
	</analytic>
	<monogr>
		<title level="j">Nephron -Physiol</title>
		<imprint>
			<biblScope unit="volume">118</biblScope>
			<biblScope unit="page" from="45" to="51" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Series Introduction: the immuno-neuroendocrine interface</title>
		<author>
			<persName><forename type="first">S</forename><surname>Melmed</surname></persName>
		</author>
		<idno type="DOI">10.1172/jci14604</idno>
		<ptr target="https://doi.org/10.1172/jci14604" />
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">108</biblScope>
			<biblScope unit="page" from="1563" to="1566" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">Endotoxin increases vasopressin release independently of known physiological stimuli</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">W</forename><surname>Kasting</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Mazurek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Martin</surname></persName>
		</author>
		<idno type="DOI">10.1152/ajpendo.1985.248.4.e420</idno>
		<ptr target="https://doi.org/10.1152/ajpendo.1985.248.4.e420" />
	</analytic>
	<monogr>
		<title level="j">Am J Physiol -Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<date type="published" when="1985">1985</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">COVID-19: Immunology and treatment options</title>
		<author>
			<persName><forename type="first">S</forename><surname>Felsenstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Herbert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Mcnamara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Hedrich</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.clim.2020.108448</idno>
		<ptr target="https://doi.org/10.1016/j.clim.2020.108448" />
	</analytic>
	<monogr>
		<title level="j">Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">215</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<monogr>
		<title level="m" type="main">Elementary immunology : Na + as a regulator of immunity</title>
		<author>
			<persName><forename type="first">V</forename><surname>Schatz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Neubert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>SchrÃ¶der</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Binger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gebhard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">N</forename><surname>MÃ¼ller</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00467-016-3349-x</idno>
		<ptr target="https://doi.org/10.1007/s00467-016-3349-x" />
		<imprint>
			<date type="published" when="2017">2017</date>
			<biblScope unit="page" from="201" to="210" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">Effects of dietary salt levels on monocytic cells and immune responses in healthy human subjects: A longitudinal study</title>
		<author>
			<persName><forename type="first">B</forename><surname>Yi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Titze</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rykova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Feuerecker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Vassilieva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Nichiporuk</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.trsl.2014.11.007</idno>
		<ptr target="https://doi.org/10.1016/j.trsl.2014.11.007" />
	</analytic>
	<monogr>
		<title level="j">Transl Res</title>
		<imprint>
			<biblScope unit="volume">166</biblScope>
			<biblScope unit="page" from="103" to="110" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">Dietary salt, airway inflammation, and diffusion capacity in exercise-induced asthma</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">D</forename><surname>Mickleborough</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Lindley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ray</surname></persName>
		</author>
		<idno type="DOI">10.1249/01.mss.0000166949.11296.2b</idno>
		<ptr target="https://doi.org/10.1249/01.mss.0000166949.11296.2b" />
	</analytic>
	<monogr>
		<title level="j">Med Sci Sports Exerc</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="904" to="914" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">Infusion of hypertonic saline (7.5% NaCl) causes minor immunological changes in normovolaemic women</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Kolsen-Petersen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jod</forename><surname>Nielsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Bendtzen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Tonnesen</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.0001-5172.2004.00301.x</idno>
		<ptr target="https://doi.org/10.1111/j.0001-5172.2004.00301.x" />
	</analytic>
	<monogr>
		<title level="j">Acta Anaesthesiol Scand</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="224" to="233" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">Immune effect of hypertonic saline: Fact or fiction?</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>KÃ¸lsen-Petersen</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1399-6576.2004.00396.x</idno>
		<ptr target="https://doi.org/10.1111/j.1399-6576.2004.00396.x" />
	</analytic>
	<monogr>
		<title level="j">Acta Anaesthesiol Scand</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="667" to="678" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">NF-ÎºB and the immune response</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Hayden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>West</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ghosh</surname></persName>
		</author>
		<idno type="DOI">10.1038/sj.onc.1209943</idno>
		<ptr target="https://doi.org/10.1038/sj.onc.1209943" />
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="6758" to="6780" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main">Hypertonic saline enhances cellular immune function</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">G</forename><surname>Junger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">C</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Loomis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Hoyt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circ Shock</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="190" to="196" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main">Stimulation of TNFÎ± expression by hyperosmotic stress</title>
		<author>
			<persName><forename type="first">K</forename><surname>Lang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Fillon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Schneider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">G</forename><surname>Rammensee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Lang</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00424-001-0768-7</idno>
		<ptr target="https://doi.org/10.1007/s00424-001-0768-7" />
	</analytic>
	<monogr>
		<title level="j">Pflugers Arch Eur J Physiol</title>
		<imprint>
			<biblScope unit="volume">443</biblScope>
			<biblScope unit="page" from="798" to="803" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main">High salt primes a specific activation state of macrophages, M(Na)</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">C</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">J</forename><surname>Zheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Y</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">X</forename><surname>Shen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Shi</surname></persName>
		</author>
		<idno type="DOI">10.1038/cr.2015.87</idno>
		<ptr target="https://doi.org/10.1038/cr.2015.87" />
	</analytic>
	<monogr>
		<title level="j">Cell Res</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="893" to="910" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b71">
	<analytic>
		<title level="a" type="main">Sodium chloride promotes pro-inflammatory macrophage polarization thereby aggravating CNS autoimmunity</title>
		<author>
			<persName><forename type="first">S</forename><surname>Hucke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Eschborn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Liebmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Herold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Freise</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Engbers</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jaut.2015.11.001</idno>
		<ptr target="https://doi.org/10.1016/j.jaut.2015.11.001" />
	</analytic>
	<monogr>
		<title level="j">J Autoimmun</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="page" from="90" to="101" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<title level="a" type="main">Clinical significance of monocyte heterogeneity</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">K</forename><surname>Stansfield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Ingram</surname></persName>
		</author>
		<idno type="DOI">10.1186/s40169-014-0040-3</idno>
		<ptr target="https://doi.org/10.1186/s40169-014-0040-3" />
	</analytic>
	<monogr>
		<title level="j">Clin Transl Med</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b73">
	<analytic>
		<title level="a" type="main">Hypertonicity regulates the function of human neutrophils by modulating chemoattractant receptor signaling and activating mitogen-activated protein kinase p38</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">G</forename><surname>Junger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Hoyt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Davis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Herdon-Remelius</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Namiki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Junger</surname></persName>
		</author>
		<idno type="DOI">10.1172/JCI1354</idno>
		<ptr target="https://doi.org/10.1172/JCI1354" />
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">101</biblScope>
			<biblScope unit="page" from="2768" to="2779" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b74">
	<analytic>
		<title level="a" type="main">Hypertonic stress increases T cell interleukin-2 expression through a mechanism that involves ATP release, P2 receptor, and p38 MAPK activation</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Loomis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Namiki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Ostrom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Insel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">G</forename><surname>Junger</surname></persName>
		</author>
		<idno type="DOI">10.1074/jbc.M207868200</idno>
		<ptr target="https://doi.org/10.1074/jbc.M207868200" />
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">278</biblScope>
			<biblScope unit="page" from="4590" to="4596" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b75">
	<analytic>
		<title level="a" type="main">Bridging the NFAT and NF-ÎºB families: NFAT5 dimerization regulates cytokine gene transcription in response to osmotic stress</title>
		<author>
			<persName><forename type="first">C</forename><surname>LÃ³pez-RodrÃ­guez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Aramburu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jin</forename><forename type="middle">L</forename><surname>Rakeman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Michino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
		<idno type="DOI">10.1016/S1074-7613(01)00165-0</idno>
		<ptr target="https://doi.org/10.1016/S1074-7613(01)00165-0" />
	</analytic>
	<monogr>
		<title level="j">Immunity</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="47" to="58" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b76">
	<analytic>
		<title level="a" type="main">Context-dependent regulation of Th17-associated genes and IFNÎ³ expression by the transcription factor NFAT5</title>
		<author>
			<persName><forename type="first">M</forename><surname>Alberdi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Iglesias</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Tejedor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Merino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>LÃ³pez-RodrÃ­guez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Aramburu</surname></persName>
		</author>
		<idno type="DOI">10.1038/icb.2016.69</idno>
		<ptr target="https://doi.org/10.1038/icb.2016.69" />
	</analytic>
	<monogr>
		<title level="j">Immunol Cell Biol</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="page" from="56" to="67" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b77">
	<analytic>
		<title level="a" type="main">Induction of pathogenic TH 17 cells by inducible salt-sensing kinase SGK1</title>
		<author>
			<persName><forename type="first">C</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Yosef</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Thalhamer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Xiao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Kishi</surname></persName>
		</author>
		<idno type="DOI">10.1038/nature11984</idno>
		<ptr target="https://doi.org/10.1038/nature11984" />
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">496</biblScope>
			<biblScope unit="page" from="513" to="517" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b78">
	<analytic>
		<title level="a" type="main">Sodium chloride drives autoimmune disease by the induction of pathogenic TH 17 cells</title>
		<author>
			<persName><forename type="first">M</forename><surname>Kleinewietfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Manzel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Titze</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kvakan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Yosef</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Linker</surname></persName>
		</author>
		<idno type="DOI">10.1038/nature11868</idno>
		<ptr target="https://doi.org/10.1038/nature11868" />
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">496</biblScope>
			<biblScope unit="page" from="518" to="522" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b79">
	<analytic>
		<title level="a" type="main">Sodium chloride inhibits the suppressive function of FOXP3+ regulatory T cells</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Hernandez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Lowther</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Rodriguez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Vudattu</surname></persName>
		</author>
		<idno type="DOI">10.1172/JCI81151</idno>
		<ptr target="https://doi.org/10.1172/JCI81151" />
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">125</biblScope>
			<biblScope unit="page" from="4212" to="4222" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b80">
	<analytic>
		<title level="a" type="main">Review article</title>
		<author>
			<persName><forename type="first">A</forename><surname>Shukla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Hashiguchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Coimbra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Hoyt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">G</forename><surname>Junger</surname></persName>
		</author>
		<idno type="DOI">10.1097/01.shk.0000125478.37219.48</idno>
		<ptr target="https://doi.org/10.1097/01.shk.0000125478.37219.48" />
	</analytic>
	<monogr>
		<title level="j">DNA Repair (Amst)</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="391" to="400" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b81">
	<analytic>
		<title level="a" type="main">The impact of hyperosmolality on activation and differentiation of B lymphoid cells</title>
		<author>
			<persName><forename type="first">L</forename><surname>Cvetkovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Perisic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Titze</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H-M</forename><surname>JÃ¤ck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Schuh</surname></persName>
		</author>
		<idno type="DOI">10.3389/fimmu.2019.00828</idno>
		<ptr target="https://doi.org/10.3389/fimmu.2019.00828" />
	</analytic>
	<monogr>
		<title level="j">Front Immunol</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">828</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b82">
	<analytic>
		<title level="a" type="main">Role of p38 mitogen-activated protein kinase on cardiac dysfunction after hemorrhagic shock in rats</title>
		<author>
			<persName><forename type="first">H</forename><surname>Sato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Tanaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kasai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Tanaka</surname></persName>
		</author>
		<idno type="DOI">10.1097/SHK.0b013e3180326e3d</idno>
		<ptr target="https://doi.org/10.1097/SHK.0b013e3180326e3d" />
	</analytic>
	<monogr>
		<title level="j">Shock</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="291" to="299" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b83">
	<analytic>
		<title level="a" type="main">Identification of expression patterns associated with hemorrhage and resuscitation: integrated approach to data analysis</title>
		<author>
			<persName><forename type="first">H</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">B</forename><surname>Alam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Rilc</forename><surname>Querol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Rhee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Koustova</surname></persName>
		</author>
		<idno type="DOI">10.1097/01.ta.0000203699.91475.f6</idno>
		<ptr target="https://doi.org/10.1097/01.ta.0000203699.91475.f6" />
	</analytic>
	<monogr>
		<title level="j">J Trauma --Inj Infect Crit Care</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="701" to="724" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b84">
	<analytic>
		<title level="a" type="main">Hypertonic saline enhances cellular immune function</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">G</forename><surname>Junger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">C</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Whhd</forename><surname>Loomis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circ Shock</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="190" to="196" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b85">
	<analytic>
		<title level="a" type="main">Nacystelyn inhibits oxidant-mediated interleukin-8 expression and NF-ÎºB nuclear binding in alveolar epithelial cells</title>
		<author>
			<persName><forename type="first">F</forename><surname>Antonicelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Parmentier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Drost</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Hirani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Rahman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Donaldson</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0891-5849(01)00820-6</idno>
		<ptr target="https://doi.org/10.1016/S0891-5849(01)00820-6" />
	</analytic>
	<monogr>
		<title level="j">Free Radic Biol Med</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="492" to="502" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b86">
	<analytic>
		<title level="a" type="main">Modulation of ICAM-1 expression by extracellular glutathione in hyperoxia-exposed human pulmonary artery endothelial cells</title>
		<author>
			<persName><forename type="first">T</forename><surname>Aoki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Suzuki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Suzuki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Miyata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Oyamada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Takasugi</surname></persName>
		</author>
		<idno type="DOI">10.1165/ajrcmb.15.3.8810635</idno>
		<ptr target="https://doi.org/10.1165/ajrcmb.15.3.8810635" />
	</analytic>
	<monogr>
		<title level="j">Am J Respir Cell Mol Biol</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="319" to="327" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b87">
	<analytic>
		<title level="a" type="main">Glutathione fine-tunes the innate immune response toward antiviral pathways in a macrophage cell line independently of its antioxidant properties</title>
		<author>
			<persName><forename type="first">M</forename><surname>Diotallevi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Checconi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">T</forename><surname>Palamara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Celestino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Coppo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Holmgren</surname></persName>
		</author>
		<idno type="DOI">10.3389/fimmu.2017.01239</idno>
		<ptr target="https://doi.org/10.3389/fimmu.2017.01239" />
	</analytic>
	<monogr>
		<title level="j">Front Immunol</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b88">
	<analytic>
		<title level="a" type="main">Depletion of glutathione from brain cells in hyponatremia</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">C</forename><surname>Clark</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Baer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Sterns</surname></persName>
		</author>
		<idno type="DOI">10.1038/ki.1996.66</idno>
		<ptr target="https://doi.org/10.1038/ki.1996.66" />
	</analytic>
	<monogr>
		<title level="j">Kidney Int</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="page" from="470" to="476" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b89">
	<analytic>
		<title level="a" type="main">Environmental toxicity, redox signaling and lung inflammation: The role of glutathione</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Biswas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Rahman</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.mam.2008.07.001</idno>
		<ptr target="https://doi.org/10.1016/j.mam.2008.07.001" />
	</analytic>
	<monogr>
		<title level="j">Mol Aspects Med</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="60" to="76" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b90">
	<analytic>
		<title level="a" type="main">Oxidized glutathione is increased in the alveolar fluid of patients with the adult respiratory distress syndrome</title>
		<author>
			<persName><forename type="first">E</forename><surname>Bunnell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">R</forename><surname>Pacht</surname></persName>
		</author>
		<idno type="DOI">10.1164/ajrccm/148.5.1174</idno>
		<ptr target="https://doi.org/10.1164/ajrccm/148.5.1174" />
	</analytic>
	<monogr>
		<title level="j">Am Rev Respir Dis</title>
		<imprint>
			<biblScope unit="volume">148</biblScope>
			<biblScope unit="page" from="1174" to="1178" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b91">
	<analytic>
		<title level="a" type="main">Hypertonic saline primes activation of the p53-p21 signaling axis in human small airway epithelial cells that prevents inflammation induced by pro-inflammatory cytokines</title>
		<author>
			<persName><forename type="first">F</forename><surname>Gamboni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mitra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Reisz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Nemkov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Dzieciatkowska</surname></persName>
		</author>
		<idno type="DOI">10.1021/acs.jproteome.6b00602</idno>
		<ptr target="https://doi.org/10.1021/acs.jproteome.6b00602" />
	</analytic>
	<monogr>
		<title level="j">J Proteome Res</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="3813" to="3826" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b92">
	<analytic>
		<title level="a" type="main">Hypertonic immunomodulation is reversible and accompanied by changes in CD11b expression</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Rizoli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kapus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Parodo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Fan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">D</forename><surname>Rotstein</surname></persName>
		</author>
		<idno type="DOI">10.1006/jsre.1999.5581</idno>
		<ptr target="https://doi.org/10.1006/jsre.1999.5581" />
	</analytic>
	<monogr>
		<title level="j">J Surg Res</title>
		<imprint>
			<biblScope unit="volume">83</biblScope>
			<biblScope unit="page" from="130" to="135" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b93">
	<analytic>
		<title level="a" type="main">Vascular endothelial growth factor is a secreted angiogenic mitogen</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">W</forename><surname>Leung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Cachianes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Kuang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">V</forename><surname>Goeddel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Ferrara</surname></persName>
		</author>
		<idno type="DOI">10.1126/science.2479986</idno>
		<ptr target="https://doi.org/10.1126/science.2479986" />
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">80</biblScope>
			<biblScope unit="page" from="1306" to="1309" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b94">
	<analytic>
		<title level="a" type="main">Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">F</forename><surname>Dvorak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">F</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Detmar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Dvorak</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">146</biblScope>
			<biblScope unit="page" from="1029" to="1039" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b95">
	<analytic>
		<title level="a" type="main">Effects of vascular endothelial growth factor on hemodynamics and cardiac performance</title>
		<author>
			<persName><forename type="first">R</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bunting</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Ferrara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Keyt</surname></persName>
		</author>
		<idno type="DOI">10.1097/00005344-199606000-00011</idno>
		<ptr target="https://doi.org/10.1097/00005344-199606000-00011" />
	</analytic>
	<monogr>
		<title level="j">J Cardiovasc Pharmacol</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="838" to="844" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b96">
	<analytic>
		<title level="a" type="main">Essential role of nitric oxide in VEGF-induced, asthma-like angiogenic, inflammatory, mucus, and physiologic responses in the lung</title>
		<author>
			<persName><forename type="first">V</forename><surname>Bhandari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Choo-Wing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Chapoval</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">G</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">K</forename><surname>Kim</surname></persName>
		</author>
		<idno type="DOI">10.1073/pnas.0601057103</idno>
		<ptr target="https://doi.org/10.1073/pnas.0601057103" />
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">103</biblScope>
			<biblScope unit="page" from="11021" to="11026" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b97">
	<analytic>
		<title level="a" type="main">Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Thickett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Armstrong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Christie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Millar</surname></persName>
		</author>
		<idno type="DOI">10.1164/ajrccm.164.9.2011071</idno>
		<ptr target="https://doi.org/10.1164/ajrccm.164.9.2011071" />
	</analytic>
	<monogr>
		<title level="j">Am J Respir Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">164</biblScope>
			<biblScope unit="page" from="1601" to="1605" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b98">
	<analytic>
		<title level="a" type="main">Lung overexpression of the vascular endothelial growth factor gene induces pulmonary edema</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Kaner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">V</forename><surname>Ladetto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Singh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Fukuda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Matthay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Crystal</surname></persName>
		</author>
		<idno type="DOI">10.1165/ajrcmb.22.6.3779</idno>
		<ptr target="https://doi.org/10.1165/ajrcmb.22.6.3779" />
	</analytic>
	<monogr>
		<title level="j">Am J Respir Cell Mol Biol</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="657" to="664" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b99">
	<analytic>
		<title level="a" type="main">VEGF promotes malaria-associated acute lung injury in Mice</title>
		<author>
			<persName><forename type="first">S</forename><surname>Epiphanio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Campos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Pamplona</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Carapau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Pena</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>AtaÃ­de</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.ppat.1000916</idno>
		<ptr target="https://doi.org/10.1371/journal.ppat.1000916" />
	</analytic>
	<monogr>
		<title level="j">PLoS Pathog</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="1" to="10" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b100">
	<analytic>
		<title level="a" type="main">The acute respiratory distress syndrome: mechanisms and perspective therapeutic approaches</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Gonzales</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Lucas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Verin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Austin J Vasc Med</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b101">
	<analytic>
		<title level="a" type="main">The dual role of TNF in pulmonary edema</title>
		<author>
			<persName><forename type="first">G</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hamacher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Gorshkov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>White</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sridhar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Verin</surname></persName>
		</author>
		<idno type="DOI">10.4103/0975-3583.59983</idno>
		<ptr target="https://doi.org/10.4103/0975-3583.59983" />
	</analytic>
	<monogr>
		<title level="j">J Cardiovasc Dis Res</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="29" to="36" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b102">
	<analytic>
		<title level="a" type="main">Defective respiratory amiloride-sensitive sodium transport predisposes to pulmonary oedema and delays its resolution in mice</title>
		<author>
			<persName><forename type="first">M</forename><surname>Egli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Duplain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lepori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Cook</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Nicod</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Hummler</surname></persName>
		</author>
		<idno type="DOI">10.1113/jphysiol.2004.066704</idno>
		<ptr target="https://doi.org/10.1113/jphysiol.2004.066704" />
	</analytic>
	<monogr>
		<title level="j">J Physiol</title>
		<imprint>
			<biblScope unit="volume">560</biblScope>
			<biblScope unit="page" from="857" to="865" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b103">
	<analytic>
		<title level="a" type="main">Selected contribution: limiting Na+ transport rate in airway epithelia from Î±-ENaC transgenic mice: a model for pulmonary edema</title>
		<author>
			<persName><forename type="first">R</forename><surname>Olivier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Scherrer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Horisberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">C</forename><surname>Rossier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Hummler</surname></persName>
		</author>
		<idno type="DOI">10.1152/japplphysiol.00413.2002</idno>
		<ptr target="https://doi.org/10.1152/japplphysiol.00413.2002" />
	</analytic>
	<monogr>
		<title level="j">J Appl Physiol</title>
		<imprint>
			<biblScope unit="volume">93</biblScope>
			<biblScope unit="page" from="1881" to="1887" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b104">
	<analytic>
		<title level="a" type="main">Decreased expression of both the Î±1-and Î±2-subunits of the Na-K-ATPase reduces maximal alveolar epithelial fluid clearance</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Looney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sartori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Chakraborty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">F</forename><surname>James</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Lingrel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Matthay</surname></persName>
		</author>
		<idno type="DOI">10.1152/ajplung.00464.2004</idno>
		<ptr target="https://doi.org/10.1152/ajplung.00464.2004" />
	</analytic>
	<monogr>
		<title level="j">Am J Physiol -Lung Cell Mol Physiol</title>
		<imprint>
			<biblScope unit="volume">289</biblScope>
			<biblScope unit="page" from="104" to="110" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b105">
	<analytic>
		<title level="a" type="main">Sodium channels in alveolar epithelial cells: molecular characterization, biophysical properties, and physiological significance</title>
		<author>
			<persName><forename type="first">S</forename><surname>Matalon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O'</forename><surname>Brodovich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename></persName>
		</author>
		<idno type="DOI">10.1146/annurev.physiol.61.1.627</idno>
		<ptr target="https://doi.org/10.1146/annurev.physiol.61.1.627" />
	</analytic>
	<monogr>
		<title level="j">Annu Rev Physiol</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="page" from="627" to="661" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b106">
	<analytic>
		<title level="a" type="main">Lung epithelial fluid transport and the resolution of pulmonary edema</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Matthay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">G</forename><surname>Folkesson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Clerici</surname></persName>
		</author>
		<idno type="DOI">10.1152/physrev.00003.2002</idno>
		<ptr target="https://doi.org/10.1152/physrev.00003.2002" />
	</analytic>
	<monogr>
		<title level="j">Physiol Rev</title>
		<imprint>
			<biblScope unit="volume">82</biblScope>
			<biblScope unit="page" from="569" to="600" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b107">
	<analytic>
		<title level="a" type="main">Invited review: lung edema clearance: Role of Na +-K+-ATPase</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">I</forename><surname>Sznajder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Factor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Ingbar</surname></persName>
		</author>
		<idno type="DOI">10.1152/japplphysiol.00022.2002</idno>
		<ptr target="https://doi.org/10.1152/japplphysiol.00022.2002" />
	</analytic>
	<monogr>
		<title level="j">J Appl Physiol</title>
		<imprint>
			<biblScope unit="volume">93</biblScope>
			<biblScope unit="page" from="1860" to="1866" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b108">
	<analytic>
		<title level="a" type="main">Transient receptor potential vanilloid 4 regulates aquaporin-5 abundance under hypotonic conditions</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">K</forename><surname>Sidhaye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>GÃ¼ler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Schweitzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>'alessio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Caterina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>King</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename></persName>
		</author>
		<idno type="DOI">10.1073/pnas.0511211103</idno>
		<ptr target="https://doi.org/10.1073/pnas.0511211103" />
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">103</biblScope>
			<biblScope unit="page" from="4747" to="4752" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b109">
	<analytic>
		<title level="a" type="main">Salivary acinar cells from aquaporin 5-deficient mice have decreased membrane water permeability and altered cell volume regulation</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Krane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Melvin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Van Nguyen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Richardson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Towne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Doetschman</surname></persName>
		</author>
		<idno type="DOI">10.1074/jbc.M008760200</idno>
		<ptr target="https://doi.org/10.1074/jbc.M008760200" />
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">276</biblScope>
			<biblScope unit="page" from="23413" to="23420" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b110">
	<analytic>
		<title level="a" type="main">Function of aquaporins in sepsis: a systematic review</title>
		<author>
			<persName><forename type="first">K</forename><surname>Rump</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Adamzik</surname></persName>
		</author>
		<idno type="DOI">10.1186/s13578-018-0211-9</idno>
		<ptr target="https://doi.org/10.1186/s13578-018-0211-9" />
	</analytic>
	<monogr>
		<title level="j">Cell Biosci</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="1" to="7" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b111">
	<analytic>
		<title level="a" type="main">Effects of different resuscitation fluids on pulmonary expression of aquaporin1 and aquaporin5 in a rat model of uncontrolled hemorrhagic shock and infection</title>
		<author>
			<persName><forename type="first">J</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Du</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0064390</idno>
		<ptr target="https://doi.org/10.1371/journal.pone.0064390" />
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="1" to="7" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b112">
	<analytic>
		<title level="a" type="main">Decreased expression of aquaporin (AQP)1 and AQP5 in mouse lung after acute viral infection</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Towne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Harrod</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Krane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Menon</surname></persName>
		</author>
		<idno type="DOI">10.1165/ajrcmb.22.1.3818</idno>
		<ptr target="https://doi.org/10.1165/ajrcmb.22.1.3818" />
	</analytic>
	<monogr>
		<title level="j">Am J Respir Cell Mol Biol</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="34" to="44" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b113">
	<analytic>
		<title level="a" type="main">Differential expression of aquaporins in experimental models of acute lung injury</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Vassiliou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Manitsopoulos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kardara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Maniatis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Orfanos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kotanidou</surname></persName>
		</author>
		<idno type="DOI">10.21873/invivo.11143</idno>
		<ptr target="https://doi.org/10.21873/invivo.11143" />
	</analytic>
	<monogr>
		<title level="j">Vivo</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="885" to="894" />
			<date type="published" when="2017">2017</date>
			<pubPlace>Brooklyn</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b114">
	<analytic>
		<title level="a" type="main">Tumor necrosis factor-Î± inhibits aquaporin 5 expression in mouse lung epithelial cells</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Towne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Krane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Bachurski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Menon</surname></persName>
		</author>
		<idno type="DOI">10.1074/jbc.M100322200</idno>
		<ptr target="https://doi.org/10.1074/jbc.M100322200" />
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">276</biblScope>
			<biblScope unit="page" from="18657" to="18664" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b115">
	<analytic>
		<title level="a" type="main">Recent advances in the molecular basis of TNF signal transduction</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">C</forename><surname>Ledgerwood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Pober</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Bradley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lab Investig</title>
		<imprint>
			<biblScope unit="volume">79</biblScope>
			<biblScope unit="page" from="1041" to="1050" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b116">
	<analytic>
		<title level="a" type="main">Signal transduction by tumour necrosis factor and tumour necrosis factor related ligands and their receptors</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">G</forename><surname>Darnay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">B</forename><surname>Aggarwal</surname></persName>
		</author>
		<idno type="DOI">10.1136/ard.58.2008.i2</idno>
		<ptr target="https://doi.org/10.1136/ard.58.2008.i2" />
	</analytic>
	<monogr>
		<title level="j">Ann Rheum Dis</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b117">
	<analytic>
		<title level="a" type="main">Tumour necrosis factor Î± and interleukin 1 signalling: do MAPKK kinases connect it all?</title>
		<author>
			<persName><forename type="first">J</forename><surname>Eder</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0165-6147(97)01097-3</idno>
		<ptr target="https://doi.org/10.1016/S0165-6147(97)01097-3" />
	</analytic>
	<monogr>
		<title level="j">Trends Pharmacol Sci</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="319" to="322" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b118">
	<analytic>
		<title level="a" type="main">Small-volume resuscitation: From experimental evidence to clinical routine. Advantages and disadvantages of hypertonic solutions</title>
		<author>
			<persName><forename type="first">U</forename><surname>Kreimeier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Messmer</surname></persName>
		</author>
		<idno type="DOI">10.1034/j.1399-6576.2002.460601.x</idno>
		<ptr target="https://doi.org/10.1034/j.1399-6576.2002" />
	</analytic>
	<monogr>
		<title level="j">Acta Anaesthesiol Scand</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="625" to="638" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b119">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Stookey</surname></persName>
		</author>
		<idno type="DOI">10.1034/j.1399-6576.2002.460601.x</idno>
	</analytic>
	<monogr>
		<title level="j">Medical Hypotheses</title>
		<imprint>
			<biblScope unit="volume">144</biblScope>
			<biblScope unit="page" from="110237" to="460601" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b120">
	<analytic>
		<title level="a" type="main">Hypertonic resuscitation of hemorrhagic shock upregulates the anti-inflammatory response by alveolar macrophages</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Powers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Woo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Khadaroo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Papia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kapus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">D</forename><surname>Rotstein</surname></persName>
		</author>
		<idno type="DOI">10.1067/msy.2003.246</idno>
		<ptr target="https://doi.org/10.1067/msy.2003.246" />
	</analytic>
	<monogr>
		<title level="j">Surgery</title>
		<imprint>
			<biblScope unit="volume">134</biblScope>
			<biblScope unit="page" from="312" to="318" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b121">
	<analytic>
		<title level="a" type="main">Nebulized hypertonic saline attenuates acute lung injury following trauma and hemorrhagic shock via inhibition of matrix metalloproteinase-13</title>
		<author>
			<persName><forename type="first">M</forename><surname>Wohlauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">E</forename><surname>Moore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Silliman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fragoso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Gamboni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Harr</surname></persName>
		</author>
		<idno type="DOI">10.1097/CCM.0b013e3182592006</idno>
		<ptr target="https://doi.org/10.1097/CCM.0b013e3182592006" />
	</analytic>
	<monogr>
		<title level="j">Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="2647" to="2653" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b122">
	<analytic>
		<title level="a" type="main">Review of a large clinical series: association of cumulative fluid balance on outcome in acute lung injury: a retrospective review of the ARDSnet tidal volume study cohort</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Rosenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Dechert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">K</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Bartlett</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Intensive Care Med</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="35" to="46" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b123">
	<analytic>
		<title level="a" type="main">Comparison of two fluid-management strategies in acute lung injury</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">P</forename><surname>Wiedemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Wheeler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Bernard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">T</forename><surname>Thompson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hayden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Deboisblanc</surname></persName>
		</author>
		<idno type="DOI">10.1056/NEJMoa062200</idno>
		<ptr target="https://doi.org/10.1056/NEJMoa062200" />
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">354</biblScope>
			<biblScope unit="page" from="2564" to="2575" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b124">
	<monogr>
		<title/>
		<author>
			<persName><surname>Nhlbi Ards Network|about</surname></persName>
		</author>
		<ptr target="http://www.ardsnet.org/" />
		<imprint>
			<date type="published" when="2020-05-01">May 1, 2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b125">
	<analytic>
		<title level="a" type="main">Polymorphism of the angiotensin-converting enzyme gene affects the outcome of acute respiratory distress syndrome</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Jerng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">Y</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Yang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="1001" to="1006" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b126">
	<analytic>
		<title level="a" type="main">Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Marshall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Webb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Bellingan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">E</forename><surname>Montgomery</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Chaudhari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Mcanulty</surname></persName>
		</author>
		<idno type="DOI">10.1164/rccm.2108086</idno>
		<ptr target="https://doi.org/10.1164/rccm.2108086" />
	</analytic>
	<monogr>
		<title level="j">Am J Respir Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">166</biblScope>
			<biblScope unit="page" from="646" to="650" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b127">
	<analytic>
		<title level="a" type="main">A novel-1364A/C aquaporin 5 gene promoter polymorphism influences the responses to salt loading of the renin-angiotensin-aldosterone system and of blood pressure in young healthy men</title>
		<author>
			<persName><forename type="first">M</forename><surname>Adamzik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">H</forename><surname>Frey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Bitzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Jakob</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Baba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Schmieder</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00395-008-0750-z</idno>
		<ptr target="https://doi.org/10.1007/s00395-008-0750-z" />
	</analytic>
	<monogr>
		<title level="j">Basic Res Cardiol</title>
		<imprint>
			<biblScope unit="volume">103</biblScope>
			<biblScope unit="page" from="598" to="610" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b128">
	<analytic>
		<title level="a" type="main">Aquaporin 5 gene promoter 1364A/C polymorphism associated with 30-day survival in severe sepsis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Adamzik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">H</forename><surname>Frey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>MÃ¶hlenkamp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Scherag</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Waydhas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Marggraf</surname></persName>
		</author>
		<idno type="DOI">10.1097/ALN.0b013e31820ca911</idno>
		<ptr target="https://doi.org/10.1097/ALN.0b013e31820ca911" />
	</analytic>
	<monogr>
		<title level="j">Anesthesiology</title>
		<imprint>
			<biblScope unit="volume">114</biblScope>
			<biblScope unit="page" from="912" to="917" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b129">
	<analytic>
		<title level="a" type="main">Two liters a day keep the doctor away? Considerations on the pathophysiology of suboptimal fluid intake in the common population</title>
		<author>
			<persName><forename type="first">F</forename><surname>Lang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Guelinckx</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Lemetais</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Melander</surname></persName>
		</author>
		<idno type="DOI">10.1159/000479640</idno>
		<ptr target="https://doi.org/10.1159/000479640" />
	</analytic>
	<monogr>
		<title level="j">Kidney Blood Press Res</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="483" to="494" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b130">
	<analytic>
		<title level="a" type="main">Assessing hydration status: the elusive gold standard</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Armstrong</surname></persName>
		</author>
		<idno type="DOI">10.1080/07315724.2007.10719661</idno>
		<ptr target="https://doi.org/10.1080/07315724.2007.10719661" />
	</analytic>
	<monogr>
		<title level="j">J Am Coll Nutr</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="575S" to="5784" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b131">
	<analytic>
		<title level="a" type="main">Regulation of transport across cell membranes by the serum-and glucocorticoid-inducible kinase SGK1</title>
		<author>
			<persName><forename type="first">F</forename><surname>Lang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Stournaras</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Alesutan</surname></persName>
		</author>
		<idno type="DOI">10.3109/09687688.2013.874598</idno>
		<ptr target="https://doi.org/10.3109/09687688.2013.874598" />
	</analytic>
	<monogr>
		<title level="j">Mol Membr Biol</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="29" to="36" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b132">
	<analytic>
		<title level="a" type="main">Serum and glucocorticoid inducible kinase, metabolic syndrome, inflammation, and tumor growth</title>
		<author>
			<persName><forename type="first">F</forename><surname>Lang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Stournaras</surname></persName>
		</author>
		<idno type="DOI">10.14310/horm.2002.1401</idno>
		<ptr target="https://doi.org/10.14310/horm.2002.1401" />
	</analytic>
	<monogr>
		<title level="j">Hormones</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="160" to="171" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b133">
	<analytic>
		<title level="a" type="main">Patho) physiological significance of the serum-and glucocorticoid-inducible kinase isoforms</title>
		<author>
			<persName><forename type="first">F</forename><surname>Lang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>BÃ¶hmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Palmada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Seebohm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Strutz-Seebohm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Vallon</surname></persName>
		</author>
		<idno type="DOI">10.1152/physrev.00050.2005</idno>
		<ptr target="https://doi.org/10.1152/physrev.00050.2005" />
	</analytic>
	<monogr>
		<title level="j">Physiol Rev</title>
		<imprint>
			<biblScope unit="volume">86</biblScope>
			<biblScope unit="page" from="1151" to="1178" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b134">
	<analytic>
		<title level="a" type="main">A single NFÎºB system for both canonical and non-canonical signaling</title>
		<author>
			<persName><forename type="first">Vfs</forename><surname>Shih</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Tsui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Caldwell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hoffmann</surname></persName>
		</author>
		<idno type="DOI">10.1038/cr.2010.161</idno>
		<ptr target="https://doi.org/10.1038/cr.2010.161" />
	</analytic>
	<monogr>
		<title level="j">Cell Res</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="86" to="102" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b135">
	<analytic>
		<title level="a" type="main">NFÎºB is an unexpected major mediator of interleukin-15 signaling in cerebral endothelia</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">P</forename><surname>Stone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Kastin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Pan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Physiol Biochem</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="115" to="124" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b136">
	<analytic>
		<title level="a" type="main">Serum-and glucocorticoidregulated kinase 1 is upregulated following unilateral ureteral obstruction causing epithelial-mesenchymal transition</title>
		<author>
			<persName><forename type="first">J</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">D</forename><surname>Truong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kuhl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Lang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Du</surname></persName>
		</author>
		<idno type="DOI">10.1038/ki.2010.214</idno>
		<ptr target="https://doi.org/10.1038/ki.2010.214" />
	</analytic>
	<monogr>
		<title level="j">Kidney Int</title>
		<imprint>
			<biblScope unit="volume">78</biblScope>
			<biblScope unit="page" from="668" to="678" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b137">
	<analytic>
		<title level="a" type="main">Targeting the TGFÎ² signalling pathway in disease</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Akhurst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hata</surname></persName>
		</author>
		<idno type="DOI">10.1038/nrd3810</idno>
		<ptr target="https://doi.org/10.1038/nrd3810" />
	</analytic>
	<monogr>
		<title level="j">Nat Rev Drug Discov</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="790" to="811" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b138">
	<analytic>
		<title level="a" type="main">COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review</title>
		<author>
			<persName><forename type="first">B</forename><surname>Bikdeli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">V</forename><surname>Madhavan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Jimenez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Chuich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Dreyfus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Driggin</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jacc.2020.04.031</idno>
		<ptr target="https://doi.org/10.1016/j.jacc.2020.04.031" />
	</analytic>
	<monogr>
		<title level="j">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">75</biblScope>
			<biblScope unit="page" from="2950" to="2973" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b139">
	<analytic>
		<title level="a" type="main">Is this elderly patient dehydrated? Diagnostic accuracy of hydration assessment using physical signs, urine, and saliva markers</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Fortes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Owen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Raymond</forename><forename type="middle">-</forename><surname>Barker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Bishop</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Elghenzai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Oliver</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Med Dir Assoc</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="221" to="228" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b140">
	<analytic>
		<title level="a" type="main">Biological variation and diagnostic accuracy of dehydration assessment markers</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">N</forename><surname>Cheuvront</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">R</forename><surname>Ely</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Kenefick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">N</forename><surname>Sawka</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">92</biblScope>
			<biblScope unit="page" from="565" to="573" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b141">
	<analytic>
		<title level="a" type="main">Observations on saliva osmolality during progressive dehydration and partial rehydration</title>
		<author>
			<persName><forename type="first">Nas</forename><surname>Taylor</surname></persName>
		</author>
		<author>
			<persName><surname>Van Den</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Amj</forename><surname>Heuvel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Kerry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mcghee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">E</forename><surname>Peoples</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Brown</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00421-011-2299-z</idno>
		<ptr target="https://doi.org/10.1007/s00421-011-2299-z" />
	</analytic>
	<monogr>
		<title level="j">Eur J Appl Physiol</title>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="page" from="3227" to="3237" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b142">
	<analytic>
		<title level="a" type="main">Limitations of salivary osmolality as a marker of hydration status</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">R</forename><surname>Ely</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">N</forename><surname>Cheuvront</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Kenefick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">N</forename><surname>Sawka</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Med Sci Sports Exerc</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="1080" to="1084" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b143">
	<analytic>
		<title level="a" type="main">The salivary sodium-potassium ratio -a useful screening test for aldosteronism in hypertensive subjects</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">P</forename><surname>Lauler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Hickler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Thorn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">267</biblScope>
			<biblScope unit="page">1136</biblScope>
			<date type="published" when="1962">1962</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b144">
	<analytic>
		<title level="a" type="main">Aldosterone regulates salivary sodium secretion in cattle</title>
		<author>
			<persName><forename type="first">F</forename><surname>Riad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lefaivre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Tournaire</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Barlet</surname></persName>
		</author>
		<idno type="DOI">10.1677/joe.0.1080405</idno>
		<ptr target="https://doi.org/10.1677/joe.0.1080405" />
	</analytic>
	<monogr>
		<title level="j">J Endocrinol</title>
		<imprint>
			<biblScope unit="volume">108</biblScope>
			<biblScope unit="page" from="405" to="411" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b145">
	<monogr>
		<ptr target="https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/prevention.html" />
		<title level="m">How to Protect Yourself &amp; Others|CDC n</title>
		<imprint>
			<date type="published" when="2020-05-01">May 1, 2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b146">
	<analytic>
		<title level="a" type="main">Effect of dehydration on cardiovascular responses and electrolytes after hypertonic saline/dextran treatment for moderate hemorrhage</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Wade</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Tillman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Loveday</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Blackmon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Potanko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Hunt</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0196-0644(05)80143-X</idno>
		<ptr target="https://doi.org/10.1016/S0196-0644(05)80143-X" />
	</analytic>
	<monogr>
		<title level="j">Ann Emerg Med</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="113" to="119" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
